CN108164547B - Poly-fused ring conjugated macromolecule and preparation method and application thereof - Google Patents

Poly-fused ring conjugated macromolecule and preparation method and application thereof Download PDF

Info

Publication number
CN108164547B
CN108164547B CN201611115692.XA CN201611115692A CN108164547B CN 108164547 B CN108164547 B CN 108164547B CN 201611115692 A CN201611115692 A CN 201611115692A CN 108164547 B CN108164547 B CN 108164547B
Authority
CN
China
Prior art keywords
formula
hexyl
absent
group
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201611115692.XA
Other languages
Chinese (zh)
Other versions
CN108164547A (en
Inventor
占肖卫
代水星
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University
Original Assignee
Peking University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University filed Critical Peking University
Priority to CN201611115692.XA priority Critical patent/CN108164547B/en
Priority to PCT/CN2017/110174 priority patent/WO2018103496A1/en
Publication of CN108164547A publication Critical patent/CN108164547A/en
Application granted granted Critical
Publication of CN108164547B publication Critical patent/CN108164547B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K71/00Manufacture or treatment specially adapted for the organic devices covered by this subclass
    • H10K71/10Deposition of organic active material
    • H10K71/12Deposition of organic active material using liquid deposition, e.g. spin coating
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K30/00Organic devices sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation
    • H10K30/80Constructional details
    • H10K30/84Layers having high charge carrier mobility
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K71/00Manufacture or treatment specially adapted for the organic devices covered by this subclass
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P70/00Climate change mitigation technologies in the production process for final industrial or consumer products
    • Y02P70/50Manufacturing or production processes characterised by the final manufactured product

Abstract

The invention relates to the field of solar cells, in particular to a poly-fused ring conjugated macromolecule and a preparation method and application thereof. The poly-fused ring conjugated macromolecule is one of a compound shown in a formula (1F) and a compound shown in a formula (1). The poly-fused ring conjugated macromolecule provided by the invention has stronger light absorption, higher charge transmission performance and proper electron energy level, and is suitable for being used as an electron donor or electron acceptor material to be applied to the preparation of solar cells.
Figure DDA0001173383090000011

Description

Poly-fused ring conjugated macromolecule and preparation method and application thereof
Technical Field
The invention relates to the field of solar cells, in particular to a poly-fused ring conjugated macromolecule and a preparation method and application thereof.
Background
In recent years, organic solar cells have been rapidly developed, and have received much attention from academia and industry due to their advantages of light weight, good flexibility, simple processing method, large-area preparation, and low cost. At present, the photoelectric conversion efficiency of solar cells prepared based on blending of polymer donors and fullerene receptors has broken through by 11%. This shows a great application prospect for organic solar cells. The polymer material has higher photoelectric conversion efficiency of the photovoltaic device due to higher molar extinction coefficient and wider solar spectrum absorption. However, polymers also have disadvantages, such as: uncertain molecular structure, polydispersity molecular weight distribution, difficult batch repeatability, difficult purification and the like. Different from polymers, organic condensed ring micromolecules and macromolecular semiconductor materials have the advantages of determined molecular structures and molecular weights, stable batches, simplicity in purification, high purity and the like, so that the research of organic condensed ring micromolecules and macromolecular solar cells tends to be hot.
Due to the advantages of the fullerene derivative such as enough electron affinity, isotropic electron transport performance, relatively matched electron energy level and the like, the fullerene derivative (PC)61BM and PC71BM) become star molecules in the receptor material and always dominateAnd (5) a position. However, PCBM also has many disadvantages, such as weak visible light absorption, difficult energy level regulation, complex and tedious purification process, and the like. Therefore, the synthesis of novel receptor materials is still necessary.
Disclosure of Invention
The invention aims to provide a novel multi-fused ring conjugated macromolecule which can be used for a solar cell as an electron donor or electron acceptor material and has stronger light absorption, higher charge transmission performance and proper electron energy level, and a preparation method and application thereof.
In order to achieve the above object, the present invention provides a multiple fused ring conjugated macromolecule, which is a compound represented by the following formula (1F):
formula (1F)
Figure BDA0001173383070000011
Wherein each group
Figure BDA0001173383070000012
Each independently represents 1 to 10 thiophene conjugated fused ring structures;
each group A is independently selected from one of the groups shown in the following formulas:
Figure BDA0001173383070000021
wherein R is3-R6At least one of which is F, the others are each independently selected from H, alkyl, alkoxy and alkylthio; wherein each R is1Each independently selected from the group consisting of
Figure BDA0001173383070000022
A group shown and formula
Figure BDA0001173383070000023
A group shown; each R is2Each independently selected from the group consisting of
Figure BDA0001173383070000024
Shown inA group; each Z is independently selected from C, N and Si; each X and each Y is independently selected from O, S and Se; m is an integer of 0 to 6; p is an integer of 0 to 6; n is an integer of 0 to 6; each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, C1-C30 alkylthio, and C6-C12 aryl.
The invention also provides a preparation method of the poly-fused ring conjugated macromolecule, which comprises the following steps:
subjecting a compound represented by the following formula (2) and a compound represented by the formula (a) to a dehydration condensation reaction in the presence of a basic compound and in an organic solvent to obtain a compound represented by the formula (1F); wherein the content of the first and second substances,
formula (2)
Figure BDA0001173383070000025
Formula (a)
Figure BDA0001173383070000026
The invention also provides a poly-fused ring conjugated macromolecule, which is a compound shown in the following formula (1):
formula (1)
Figure BDA0001173383070000027
Wherein each group
Figure BDA0001173383070000028
Each independently represents 3 to 10 thiophene conjugated fused ring structures;
each group A' is independently selected from one of the groups represented by the following formulas:
Figure BDA0001173383070000029
wherein R is3-R6Each independently selected from H, alkyl, alkoxy, and alkylthio; wherein each R is1Each independently selected from the group consisting of
Figure BDA00011733830700000210
A group shown and formula
Figure BDA00011733830700000211
A group shown; each R is2Each independently selected from the group consisting of
Figure BDA00011733830700000212
A group shown; each Z is independently selected from C, N and Si; each X and each Y is independently selected from O, S and Se; m is an integer of 0 to 6; p is an integer of 0 to 6; n is an integer of 0 to 6; each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, C1-C30 alkylthio, and C6-C12 aryl.
The invention also provides a preparation method of the poly-fused ring conjugated macromolecule, which comprises the following steps:
subjecting a compound represented by the following formula (2) and a compound represented by the formula (a') to a dehydration condensation reaction in the presence of a basic compound and in an organic solvent to obtain a compound represented by the formula (1); wherein the content of the first and second substances,
formula (2)
Figure BDA0001173383070000031
Formula (a')
Figure BDA0001173383070000032
The invention also provides a photovoltaic material containing one or more of the poly-fused ring conjugated macromolecules.
The invention also provides a solar cell which comprises a light-trapping active layer, wherein the electron donor material and/or the electron acceptor material in the light-trapping active layer contain one or more of the poly-fused ring conjugated macromolecules.
The invention also provides a preparation method of the solar cell, wherein the method comprises the step of using an electron donor material and/or an electron acceptor material containing one or more of the multi-fused ring conjugated macromolecules to form a light-trapping active layer.
The poly-fused ring conjugated macromolecule provided by the invention has stronger light absorption, higher charge transmission performance and proper electron energy level, is suitable for being used as an electron donor or electron acceptor material to be applied to the preparation of solar cells, and particularly can obtain the solar cells with the photoelectric conversion efficiency of 10-12%.
Additional features and advantages of the invention will be set forth in the detailed description which follows.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention. In the drawings:
FIG. 1 shows UV-VIS absorption spectra of a polycyclic conjugated macromolecule represented by the formula (1F-5-F1) obtained in example 1 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 2 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-5-F1) obtained in example 1 of the present invention.
FIG. 3 shows UV-VIS absorption spectra of a poly-fused ring conjugated macromolecule represented by formula (1F-5-F2) obtained in example 2 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 4 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-5-F2) obtained in example 2 of the present invention.
FIG. 5 shows an ultraviolet-visible absorption spectrum of a polycyclic conjugated macromolecule represented by the formula (1F-5-13) obtained in example 3 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 6 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-5-13) obtained in example 3 of the present invention.
FIG. 7 shows UV-VIS absorption spectra of a poly-fused ring conjugated macromolecule represented by formula (1F-7-F1) obtained in example 4 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 8 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-7-F1) obtained in example 4 of the present invention.
FIG. 9 shows UV-VIS absorption spectra of poly-fused ring conjugated macromolecules represented by formula (1F-7-F3) obtained in example 5 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 10 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-7-F3) obtained in example 5 of the present invention.
FIG. 11 is an ultraviolet-visible absorption spectrum of a polycyclic conjugated macromolecule represented by the formula (1F-7-15) obtained in example 6 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 12 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-7-15) obtained in example 6 of the present invention.
FIG. 13 is a UV-VIS absorption spectrum of a polycyclic conjugated macromolecule represented by the formula (1F-9-F1) prepared in example 7 according to the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 14 is a cyclic voltammogram of a polyatomic fused ring conjugated macromolecule represented by formula (1F-9-F1) obtained in example 7 of the present invention.
FIG. 15 shows an ultraviolet-visible absorption spectrum of a polycyclic conjugated macromolecule represented by the formula (1F-9-2) obtained in example 8 of the present invention, wherein the solution is represented bySolution (10) with chloroform as solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 16 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-9-2) obtained in example 8 of the present invention.
FIG. 17 shows an ultraviolet-visible absorption spectrum of a polycyclic conjugated macromolecule represented by the formula (1F-9-14) obtained in example 9 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 18 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1F-9-14) obtained in example 9 of the present invention.
FIG. 19 is an ultraviolet-visible absorption spectrum of a polycyclic conjugated macromolecule represented by the formula (1-9-2) obtained in example 10 of the present invention, wherein the solution is a solution (10) prepared using chloroform as a solvent-6mol/L) of the film is a film (100 nm in thickness) formed by spin coating chloroform solution.
FIG. 20 is a cyclic voltammogram of a poly-fused ring conjugated macromolecule represented by formula (1-9-2) obtained in example 10 of the present invention.
FIG. 21 is an I-V curve of the solar cell obtained in example 13. FIG. 22 is an I-V curve of the solar cell obtained in example 14. FIG. 23 is an I-V curve of the solar cell obtained in example 15. FIG. 24 is an I-V curve of the solar cell obtained in example 16. FIG. 25 is an I-V curve of the solar cell obtained in example 17. FIG. 26 is an I-V curve of the solar cell obtained in example 18. FIG. 27 is an I-V curve of a solar cell obtained in example 19. FIG. 28 is an I-V curve of the solar cell obtained in example 20. FIG. 29 is an I-V curve of the solar cell obtained in example 21. FIG. 30 is an I-V curve of a solar cell obtained in example 22. FIG. 31 is an I-V curve of a solar cell obtained in example 23. FIG. 32 is an I-V curve of a solar cell obtained in example 24.
Detailed Description
The following describes in detail specific embodiments of the present invention. It should be understood that the detailed description and specific examples, while indicating the present invention, are given by way of illustration and explanation only, not limitation.
The endpoints of the ranges and any values disclosed herein are not limited to the precise range or value, and such ranges or values should be understood to encompass values close to those ranges or values. For ranges of values, between the endpoints of each of the ranges and the individual points, and between the individual points may be combined with each other to give one or more new ranges of values, and these ranges of values should be considered as specifically disclosed herein.
In the present invention, each group is independently selected from the group represented, and when each group occurs simultaneously and at multiple positions in the compound, they are independently selected, may be the same, or may be different, for example, although
Figure BDA0001173383070000051
Having two R in the group shown7However, the two R7Are independently selectable, and may be the same or different.
In the present invention,
Figure BDA0001173383070000052
the dashed lines in the structures with dashed connecting bonds indicate the connecting sites and indicate the connecting bonds;
Figure BDA0001173383070000053
the solid line in the structure with the solid line connecting bond not connecting any group or atom also indicates the connecting site, representing the connecting bond.
In the present invention, the composition contains
Figure BDA0001173383070000054
The groups are such that F is taken on both the left and right sides of the bond through which-F is inserted, for example, the following formula (1F-5-F1) means in fact that the formula (1F-5-5) in which the groups A on both sides are the groups A-2, the formula (1F-5-8) in which the groups A on both sides are the groups A-3, and the groups A on both sides are one group A-3 and the other group AA mixture of compounds represented by the formula (1F-5-35) each being a group A-2.
The invention provides a poly-fused ring conjugated macromolecule, which is a compound shown in the following formula (1F):
formula (1F)
Figure BDA0001173383070000061
Wherein each group
Figure BDA0001173383070000062
Each independently represents 1 to 10 thiophene conjugated fused ring structures;
each group A is independently selected from one of the groups shown in the following formulas:
Figure BDA0001173383070000063
wherein R is3-R6At least one of which is F, the others are each independently selected from H, alkyl, alkoxy and alkylthio; wherein each R is1Each independently selected from the group consisting of
Figure BDA0001173383070000064
The radicals shown (preferably)
Figure BDA0001173383070000065
) And formula
Figure BDA0001173383070000066
A group shown; each R is2Each independently selected from the group consisting of
Figure BDA0001173383070000067
The radicals shown (preferably)
Figure BDA0001173383070000068
) (ii) a Each Z is independently selected from C, N and Si; each X and each Y is independently selected from O, S and Se; m is an integer of 0 to 6; p is an integer of 0 to 6; n is an integer of 0 to 6; each R is7Each R8Each of themR is9Each R10And each R11Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, C1-C20 alkylthio, and C6-C12 aryl.
According to the present invention, in order to obtain a conjugated macromolecule having stronger light absorption, higher charge transport property and more suitable electron energy level, it is preferable that each group
Figure BDA0001173383070000069
Each independently represents 1 to 5 thiophene conjugated fused ring structures; r3-R6At least one of which is F, the others are each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, and C1-C30 alkylthio; each Z is independently selected from C, N and Si; each X and each Y is independently selected from O and S; m is an integer of 0 to 4; p is an integer of 0 to 4; n is an integer of 0 to 4; each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, C1-C20 alkylthio, and C6-C10 aryl.
More preferably, each group
Figure BDA00011733830700000610
Each independently represents 1 to 4 thiophene conjugated fused ring structures; r3-R6At least one of which is F, the others are each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, and C1-C20 alkylthio; each Z is independently selected from C and N; each R is7Each R9And each R11Each independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy, and C1-C6 alkylthio; each R is8And each R10And each independently selected from the group consisting of H, C4-C10 alkyl, C4-C10 alkoxy, and C4-C10 alkylthio.
Even more preferably, R3-R6At least one of which is F, the others are each independently selected from the group consisting of H, C1-C10 alkyl, C1-C10 alkoxy, and C1-C10 alkylthio; each Z is independently selected from C and N; m is 0, 1, 2 or 3; p is 0, 1, 2 or 3; n is 0, 1, 2 or 3; each one ofR is7Each R9And each R11Each independently selected from H, methyl, ethyl, n-propyl, n-butyl, methoxy, ethoxy, n-propoxy, n-butoxy, methylthio, ethylthio, n-propylthio, and n-butylthio; each R is8And each R10And each is independently selected from the group consisting of H, n-butyl, n-pentyl, n-hexyl, n-octyl, 2-ethylhexyl, n-butoxy, n-pentoxy, n-hexoxy, n-octoxy, 2-ethylhexoxy, n-butylthio, n-pentoxy, n-hexoxy, n-octoxy, and 2-ethylhexoxy.
Where n is 0, R can be considered to be2When the substituent is absent, the group A is directly bonded to the fused ring unit main body of the compound represented by the formula (1F) to form a conjugated structure. Specific examples of the alkyl group having C1 to C10 may be, for example: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, 2-ethylhexyl, and the like. Alkyl groups within other ranges of the present invention may also be selected from the specific examples as appropriate. Specific examples of the alkoxy group having C1 to C10 include: methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, 2-ethylhexoxy and the like. The alkoxy group in the other ranges of the present invention can be selected from the specific examples as appropriate. Specific examples of the alkylthio group having from C1 to C10 include, for example: methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, tert-butylthio, n-pentylthio, n-hexylthio, n-heptylthio, n-octylthio, n-nonylthio, n-decylthio, 2-ethylhexylthio and the like. Specific examples of the aryl group having C6 to C10 may be, for example: phenyl, benzyl, p-tolyl, and the like.
Wherein, two groups located at both sides of the conjugated structure in the middle of the compound (1F)
Figure BDA0001173383070000071
It is to be understood as being co-centered with the compound (1F)The yoke structures together form a conjugated structure, wherein the yoke structures respectively and independently represent 1-10 thiophene conjugated condensed ring structures, and when the group B is 1 thiophene conjugated condensed ring structure, actually, 1 thiophene group and the middle conjugated structure at two sides form a basic structure of a conjugated macromolecule.
Preferably, the conjugated macromolecule is one of the compounds shown in the following formula:
formula (1F-5):
Figure BDA0001173383070000072
(corresponding to 1 thiophene conjugated condensed ring structure in all groups B); formula (1F-7):
Figure BDA0001173383070000073
(corresponding to 2 thiophene conjugated condensed ring structures in all groups B); formula (1F-9):
Figure BDA0001173383070000074
(corresponding to 3 thiophene conjugated condensed ring structures in all groups B); formula (1F-11):
Figure BDA0001173383070000075
(corresponding to 4 thiophene conjugated condensed ring structures in all groups B).
According to the invention, the group A has a strong electron pulling effect, and the group A is positioned at two ends of a condensed ring unit, so that the obtained conjugated macromolecule has strong visible light absorption capacity, high charge transmission performance and proper electron energy level, and is suitable for being used as an electron donor or electron acceptor material to be applied to preparing an organic solar cell.
Preferably, the group a is selected from one or more of the following groups:
the radical A-1 is
Figure BDA0001173383070000081
The group A-2 is
Figure BDA0001173383070000082
The radical A-3 is
Figure BDA0001173383070000083
The group A-4 is
Figure BDA0001173383070000084
The radical A-5 is
Figure BDA0001173383070000085
The radical A-6 is
Figure BDA0001173383070000086
The radical A-7 is
Figure BDA0001173383070000087
The radical A-8 is
Figure BDA0001173383070000088
The radical A-9 is
Figure BDA0001173383070000089
The radical A-10 is
Figure BDA00011733830700000810
The radical A-11 is
Figure BDA00011733830700000811
According to the present invention, the polyacene ring conjugated macromolecule of the present invention is preferably one of the compounds represented by the following formula:
formula (1F-5-1): in the formula (1F-5), Z is C, A is A-1, R2Is absent, R1Are both n-hexyl; formula (1F-5-2): in the formula (1F-5), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA00011733830700000812
And R is10Is n-hexyl; formula (1F-5-3): in the formula (1F-5), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA00011733830700000813
And R is8Is n-hexyl; formula (1F-5-4): formula (1F-5) Wherein Z is C, A is a group A-2, R2Is absent, R1Are both n-hexyl; formula (1F-5-5): in the formula (1F-5), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA00011733830700000814
And R is10Is n-hexyl; formula (1F-5-6): in the formula (1F-5), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA00011733830700000815
And R is8Is n-hexyl; formula (1F-5-7): in the formula (1F-5), Z is C, A is A-3, R2Is absent, R1Are both n-hexyl; formula (1F-5-8): in the formula (1F-5), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700000816
And R is10Is n-hexyl; formula (1F-5-9): in the formula (1F-5), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700000817
And R is8Is n-hexyl; formula (1F-5-10): in the formula (1F-5), Z is C, A is A-4, R2Is absent, R1Are both n-hexyl; formula (1F-5-11): in the formula (1F-5), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure BDA00011733830700000818
And R is10Is n-hexyl; formula (1F-5-12): in the formula (1F-5), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure BDA00011733830700000819
And R is8Is n-hexyl; formula (1F-5-13): in the formula (1F-5), Z is C, A is A-5, R2Is absent, R1Are both n-hexyl;formula (1F-5-14): in the formula (1F-5), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure BDA00011733830700000820
And R is10Is n-hexyl; formula (1F-5-15): in the formula (1F-5), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure BDA0001173383070000091
And R is8Is n-hexyl; formula (1F-5-16): in the formula (1F-5), Z is C, A is A-6, R2Is absent, R1Are both n-hexyl; formula (1F-5-17): in the formula (1F-5), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA0001173383070000092
And R is10Is n-hexyl; formula (1F-5-18): in the formula (1F-5), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA0001173383070000093
And R is8Is n-hexyl; formula (1F-5-19): in the formula (1F-5), Z is C, A is a group A-7, R2Is absent, R1Are both n-hexyl; formula (1F-5-20): in the formula (1F-5), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA0001173383070000094
And R is10Is n-hexyl; formula (1F-5-21): in the formula (1F-5), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA0001173383070000095
And R is8Is n-hexyl; formula (1F-5-22): in the formula (1F-5), Z is C, A is A-8, R2Is absent, R1Are both n-hexyl; formula (1F-5-23): in the formula (1F-5), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA0001173383070000096
And R is10Is n-hexyl; formula (1F-5-24): in the formula (1F-5), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA0001173383070000097
And R is8Is n-hexyl; formula (1F-5-25): in the formula (1F-5), Z is C, A is A-9, R2Is absent, R1Are both n-hexyl; formula (1F-5-26): in the formula (1F-5), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA0001173383070000098
And R is10Is n-hexyl; formula (1F-5-27): in the formula (1F-5), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA0001173383070000099
And R is8Is n-hexyl; formula (1F-5-28): in the formula (1F-5), Z is C, A is A-10, R2Is absent, R1Are both n-hexyl; formula (1F-5-29): in the formula (1F-5), Z is C, A is A-10, R2Is absent, R1Are all made of
Figure BDA00011733830700000910
And R is10Is n-hexyl; formula (1F-5-30): in the formula (1F-5), Z is C, A is A-10, R2Is absent, R1Are all made of
Figure BDA00011733830700000911
And R is8Is n-hexyl; formula (1F-5-31): in the formula (1F-5), Z is C, A is a group A-11, R2Is absent, R1Are both n-hexyl; formula (1F-5-32): in the formula (1F-5), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA00011733830700000912
And R is10Is n-hexyl; formula (1F-5-33): in the formula (1F-5), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA00011733830700000913
And R is8Is n-hexyl; formula (1F-5-34): in the formula (1F-5), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are both n-hexyl; formula (1F-5-35): in the formula (1F-5), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700000914
And R is10Is n-hexyl; formula (1F-5-36): in the formula (1F-5), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700000915
And R is8Is n-hexyl;
formula (1F-7-1): in the formula (1F-7), Z is C, A is A-1, R2Is absent, R1Are both n-hexyl; formula (1F-7-2): in the formula (1F-7), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA0001173383070000101
And R is10Is n-hexyl; formula (1F-7-3): in the formula (1F-7), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA0001173383070000102
And R is8Is n-hexyl; formula (1F-7-4): in the formula (1F-7), Z is C, A is A-2, R2Is absent, R1Are both n-hexyl; formula (1F-7-5): in the formula (1F-7), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA0001173383070000103
And R is10Is n-hexyl; formula (1F-7-6): in the formula (1F-7), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA0001173383070000104
And R is8Is n-hexyl; formula (1F-7-7): in the formula (1F-7), Z is C, A is A-3, R2Is absent, R1Are both n-hexyl; formula (1F-7-8): in the formula (1F-7), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000105
And R is10Is n-hexyl; formula (1F-7-9): in the formula (1F-7), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000106
And R is8Is n-hexyl; formula (1F-7-10): in the formula (1F-7), Z is C, A is A-4, R2Is absent, R1Are both n-hexyl; formula (1F-7-11): in the formula (1F-7), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure BDA0001173383070000107
And R is10Is n-hexyl; formula (1F-7-12): (1F-7) wherein Z is C and A is a group A-4, R2Is absent, R1Are all made of
Figure BDA0001173383070000108
And R is8Is n-hexyl; formula (1F-7-13): in the formula (1F-7), Z is C, A is A-5, R2Is absent, R1Are both n-hexyl; formula (1F-7-14): in the formula (1F-7), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure BDA0001173383070000109
And R is10Is n-hexyl(ii) a Formula (1F-7-15): in the formula (1F-7), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure BDA00011733830700001010
And R is8Is n-hexyl; formula (1F-7-16): in the formula (1F-7), Z is C, A is A-6, R2Is absent, R1Are both n-hexyl; formula (1F-7-17): in the formula (1F-7), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA00011733830700001011
And R is10Is n-hexyl; formula (1F-7-18): in the formula (1F-7), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA00011733830700001012
And R is8Is n-hexyl; formula (1F-7-19): in the formula (1F-7), Z is C, A is a group A-7, R2Is absent, R1Are both n-hexyl; formula (1F-7-20): in the formula (1F-7), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA00011733830700001013
And R is10Is n-hexyl; formula (1F-7-21): in the formula (1F-7), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA00011733830700001014
And R is8Is n-hexyl; formula (1F-7-22): in the formula (1F-7), Z is C, A is A-8, R2Is absent, R1Are both n-hexyl; formula (1F-7-23): in the formula (1F-7), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA00011733830700001015
And R is10Is n-hexyl; formula (1F-7-24): in the formula (1F-7), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA00011733830700001016
And R is8Is n-hexyl; formula (1F-7-25): in the formula (1F-7), Z is C, A is A-9, R2Is absent, R1Are both n-hexyl; formula (1F-7-26): in the formula (1F-7), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA0001173383070000111
And R is10Is n-hexyl; formula (1F-7-27): in the formula (1F-7), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA0001173383070000112
And R is8Is n-hexyl; formula (1F-7-28): in the formula (1F-7), Z is C, A is A-10, R2Is absent, R1Are both n-hexyl; formula (1F-7-29): in the formula (1F-7), Z is C, A is A-10, R2Is absent, R1Are all made of
Figure BDA0001173383070000113
And R is10Is n-hexyl; formula (1F-7-30): in the formula (1F-7), Z is C, A is A-10, R2Is absent, R1Are all made of
Figure BDA0001173383070000114
And R is8Is n-hexyl; formula (1F-7-31): in the formula (1F-7), Z is C, A is a group A-11, R2Is absent, R1Are both n-hexyl; formula (1F-7-32): in the formula (1F-7), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA0001173383070000115
And R is10Is n-hexyl; formula (1F-7-33): in the formula (1F-7), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA0001173383070000116
And R is8Is n-hexyl; formula (1F-7-34): in the formula (1F-7), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are both n-hexyl; formula (1F-7-35): in the formula (1F-7), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000117
And R is10Is n-hexyl; formula (1F-7-36): in the formula (1F-7), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000118
And R is8Is n-hexyl;
formula (1F-9-1): in the formula (1F-9), Z is C, A is A-1, R2Is absent, R1Are both n-hexyl; formula (1F-9-2): in the formula (1F-9), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA0001173383070000119
And R is10Is n-hexyl; formula (1F-9-3): in the formula (1F-9), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA00011733830700001110
And R is8Is n-hexyl; formula (1F-9-4): in the formula (1F-9), Z is C, A is A-2, R2Is absent, R1Are both n-hexyl; formula (1F-9-5): in the formula (1F-9), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA00011733830700001111
And R is10Is n-hexyl; formula (1F-9-6): in the formula (1F-9), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA00011733830700001112
And R is8Is n-hexyl; formula (1F-9-7): in the formula (1F-9), Z is C, A is A-3, R2Is absent, R1Are both n-hexyl; formula (1F-9-8): in the formula (1F-9), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700001113
And R is10Is n-hexyl; formula (1F-9-9): in the formula (1F-9), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700001114
And R is8Is n-hexyl; formula (1F-9-10): in the formula (1F-9), Z is C, A is A-4, R2Is absent, R1Are both n-hexyl; formula (1F-9-11): in the formula (1F-9), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure BDA00011733830700001115
And R is10Is n-hexyl; formula (1F-9-12): in the formula (1F-9), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure BDA00011733830700001116
And R is8Is n-hexyl; formula (1F-9-13): in the formula (1F-9), Z is C, A is A-5, R2Is absent, R1Are both n-hexyl; formula (1F-9-14): in the formula (1F-9), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure BDA0001173383070000121
And R is10Is n-hexyl; formula (1F-9-15): in the formula (1F-9), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure BDA0001173383070000122
And R is8Is n-hexyl; formula (1F-9-16): in the formula (1F-9), Z is C, A is A-6, R2Is absent, R1Are both n-hexyl; formula (1F-9-17): in the formula (1F-9), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA0001173383070000123
And R is10Is n-hexyl; formula (1F-9-18): in the formula (1F-9), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA0001173383070000124
And R is8Is n-hexyl; formula (1F-9-19): in the formula (1F-9), Z is C, A is a group A-7, R2Is absent, R1Are both n-hexyl; formula (1F-9-20): in the formula (1F-9), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA0001173383070000125
And R is10Is n-hexyl; formula (1F-9-21): in the formula (1F-9), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA0001173383070000126
And R is8Is n-hexyl; formula (1F-9-22): in the formula (1F-9), Z is C, A is A-8, R2Is absent, R1Are both n-hexyl; formula (1F-9-23): in the formula (1F-9), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA0001173383070000127
And R is10Is n-hexyl; formula (1F-9-24): in the formula (1F-9), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA0001173383070000128
And R is8Is n-hexyl; formula (1F-9-25): in the formula (1F-9), Z is C, A is A-9, R2Is absent from,R1Are both n-hexyl; formula (1F-9-26): in the formula (1F-9), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA0001173383070000129
And R is10Is n-hexyl; formula (1F-9-27): in the formula (1F-9), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA00011733830700001210
And R is8Is n-hexyl; formula (1F-9-28): in the formula (1F-9), Z is C, A is a group A-10, R2Is absent, R1Are both n-hexyl; formula (1F-9-29): in the formula (1F-9), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure BDA00011733830700001211
And R is10Is n-hexyl; formula (1F-9-30): in the formula (1F-9), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure BDA00011733830700001212
And R is8Is n-hexyl; formula (1F-9-31): in the formula (1F-9), Z is C, A is a group A-11, R2Is absent, R1Are both n-hexyl; formula (1F-9-32): in the formula (1F-9), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA00011733830700001213
And R is10Is n-hexyl; formula (1F-9-33): in the formula (1F-9), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA00011733830700001214
And R is8Is n-hexyl; formula (1F-9-34): in the formula (1F-9), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are both n-hexyl; formula (1F-9-35): formula (1F-9)Wherein Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700001215
And R is10Is n-hexyl; formula (1F-9-36): in the formula (1F-9), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000131
And R is8Is n-hexyl;
formula (1F-11-1): in the formula (1F-11), Z is C, A is A-1, R2Is absent, R1Are both n-hexyl; formula (1F-11-2): in the formula (1F-11), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA0001173383070000132
And R is10Is n-hexyl; formula (1F-11-3): in the formula (1F-11), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure BDA0001173383070000133
And R is8Is n-hexyl; formula (1F-11-4): in the formula (1F-11), Z is C, A is A-2, R2Is absent, R1Are both n-hexyl; formula (1F-11-5): in the formula (1F-11), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA0001173383070000134
And R is10Is n-hexyl; formula (1F-11-6): in the formula (1F-11), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure BDA0001173383070000135
And R is8Is n-hexyl; formula (1F-11-7): in the formula (1F-11), Z is C, A is A-3, R2Is absent, R1Are both n-hexyl; formula (1F-11-8): formula (1)F-11), Z is C, A is a group A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000136
And R is10Is n-hexyl; formula (1F-11-9): in the formula (1F-11), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000137
And R is8Is n-hexyl; formula (1F-11-10): in the formula (1F-11), Z is C, A is A-4, R2Is absent, R1Are both n-hexyl; formula (1F-11-11): in the formula (1F-11), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure BDA0001173383070000138
And R is10Is n-hexyl; formula (1F-11-12): in the formula (1F-11), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure BDA0001173383070000139
And R is8Is n-hexyl; formula (1F-11-13): in the formula (1F-11), Z is C, A is a group A-5, R2Is absent, R1Are both n-hexyl; formula (1F-11-14): in the formula (1F-11), Z is C, A is a group A-5, R2Is absent, R1Are all made of
Figure BDA00011733830700001310
And R is10Is n-hexyl; formula (1F-11-15): in the formula (1F-11), Z is C, A is a group A-5, R2Is absent, R1Are all made of
Figure BDA00011733830700001311
And R is8Is n-hexyl; formula (1F-11-16): in the formula (1F-11), Z is C, A is A-6, R2Is absent, R1Are both n-hexyl; formula (1F-11-17): in the formula (1F-11), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA00011733830700001312
And R is10Is n-hexyl; formula (1F-11-18): in the formula (1F-11), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure BDA00011733830700001313
And R is8Is n-hexyl; formula (1F-11-19): in the formula (1F-11), Z is C, A is a group A-7, R2Is absent, R1Are both n-hexyl; formula (1F-11-20): in the formula (1F-11), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA00011733830700001314
And R is10Is n-hexyl; formula (1F-11-21): in the formula (1F-11), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure BDA00011733830700001315
And R is8Is n-hexyl; formula (1F-11-22): in the formula (1F-11), Z is C, A is A-8, R2Is absent, R1Are both n-hexyl; formula (1F-11-23): in the formula (1F-11), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA0001173383070000141
And R is10Is n-hexyl; formula (1F-11-24): in the formula (1F-11), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure BDA0001173383070000142
And R is8Is n-hexyl; formula (1F-11-25): in the formula (1F-11), Z is C, A is A-9, R2Is absent, R1Are both n-hexyl; formula (1F-11-26): in the formula (1F-11), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA0001173383070000143
And R is10Is n-hexyl; formula (1F-11-27): in the formula (1F-11), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure BDA0001173383070000144
And R is8Is n-hexyl; formula (1F-11-28): in the formula (1F-11), Z is C, A is a group A-10, R2Is absent, R1Are both n-hexyl; formula (1F-11-29): in the formula (1F-11), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure BDA0001173383070000145
And R is10Is n-hexyl; formula (1F-11-30): in the formula (1F-11), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure BDA0001173383070000146
And R is8Is n-hexyl; formula (1F-11-31): in the formula (1F-11), Z is C, A is a group A-11, R2Is absent, R1Are both n-hexyl; formula (1F-11-32): in the formula (1F-11), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA0001173383070000147
And R is10Is n-hexyl; formula (1F-11-33): in the formula (1F-11), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure BDA0001173383070000148
And R is8Is n-hexyl; formula (1F-11-34): in the formula (1F-11), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are both n-hexyl; formula (1F-11-35): in the formula (1F-11), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA0001173383070000149
And R is10Is n-hexyl; formula (1F-11-36): in the formula (1F-11), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure BDA00011733830700001410
And R is8Is n-hexyl.
The invention also provides a preparation method of the poly-fused ring conjugated macromolecule, which comprises the following steps:
subjecting a compound represented by the following formula (2) and a compound represented by the formula (a) to a dehydration condensation reaction in the presence of a basic compound and in an organic solvent to obtain a compound represented by the formula (1F); wherein the content of the first and second substances,
formula (2)
Figure BDA00011733830700001411
Formula (a)
Figure BDA00011733830700001412
In the method, the group
Figure BDA00011733830700001413
R1-R6As described above, the present invention is not described in detail herein.
Wherein, the compound shown in the formula (2) can be selected according to the structure of the poly-fused ring conjugated macromolecule, preferably, the compound shown in the formula (2) is one or more of the following formulas:
formula (2-5)
Figure BDA00011733830700001414
Formula (2-7)
Figure BDA00011733830700001415
Formula (2-9):
Figure BDA0001173383070000151
formula (2-11):
Figure BDA0001173383070000152
specific examples of the compound represented by the formula (2) may be, for example, one or more of the following formulae:
formula (2-5-1): in the formula (2-5), Z is C or R2Is absent, R1Are both n-hexyl; formula (2-5-2): in the formula (2-5), Z is C or R2Is absent, R1Are all made of
Figure BDA0001173383070000153
And R is10Is n-hexyl; formula (2-5-3): in the formula (2-5), Z is C or R2Is absent, R1Are all made of
Figure BDA0001173383070000154
And R is8Is n-hexyl; formula (2-7-1): in the formula (2-7), Z is C or R2Is absent, R1Are both n-hexyl; formula (2-7-2): in the formula (2-7), Z is C or R2Is absent, R1Are all made of
Figure BDA0001173383070000155
And R is10Is n-hexyl; formula (2-7-3): in the formula (2-7), Z is C or R2Is absent, R1Are all made of
Figure BDA0001173383070000156
And R is8Is n-hexyl; formula (2-9-1): in the formula (2-9), Z is C or R2Is absent, R1Are both n-hexyl; formula (2-9-2): in the formula (2-9), Z is C or R2Is absent, R1Are all made of
Figure BDA0001173383070000157
And R is10Is n-hexyl; formula (2-9-3): in the formula (2-9), Z is C or R2Is absent, R1Are all made of
Figure BDA0001173383070000158
And R is8Is n-hexyl; formula (2-11-1): in the formula (2-11), Z is C or R2Is absent, R1Are both n-hexyl; formula (2-11-2): in the formula (2-11), Z is C or R2Is absent, R1Are all made of
Figure BDA0001173383070000159
And R is10Is n-hexyl; formula (2-11-3): in the formula (2-11), Z is C or R2Is absent, R1Are all made of
Figure BDA00011733830700001510
And R is8Is n-hexyl.
According to the present invention, the compound represented by the formula (2) may be a commercially available product, or may be prepared by a method conventional in the art, for example, by reacting an aldehyde group with butyllithium (for example, by a method described in Adv. Mater.,2015,27, 1170-1174; J.Am. chem. Soc.,2016,138,4955-4961, etc.).
According to the present invention, the compound represented by the formula (a) may be appropriately selected according to the group a, and for example, specific examples of the compound represented by the formula (a) may include:
formula (a-1):
Figure BDA00011733830700001511
formula (a-2):
Figure BDA00011733830700001512
formula (a-3):
Figure BDA00011733830700001513
formula (a-4):
Figure BDA00011733830700001514
formula (a-5):
Figure BDA00011733830700001515
formula (a-6):
Figure BDA00011733830700001516
formula (a-7):
Figure BDA00011733830700001517
formula (a-8):
Figure BDA00011733830700001518
formula (a-9):
Figure BDA0001173383070000161
formula (a-10):
Figure BDA0001173383070000162
formula (a-11):
Figure BDA0001173383070000163
according to the present invention, the compound represented by formula (a) may be a commercially available product or may be prepared by a method conventional in the art, and will not be described herein again.
According to the present invention, the aldehyde group connected to both ends of the compound represented by formula (2) can be subjected to dehydration condensation with the compound represented by formula (a) to form the compound represented by formula (1F), wherein the amount of the compound represented by formula (2) and the compound represented by formula (a) used is not particularly limited as long as the compound represented by formula (1F) can be obtained, and preferably, the molar ratio of the compound represented by formula (2) to the compound represented by formula (a) is 1: 2-100, more preferably 1: 4-10.
According to the present invention, the reaction is carried out in the presence of a basic compound, which may be, for example, one or more of piperidine, pyridine and triethylamine, thereby making it possible to provide a basic environment to the reaction system. The amount of the basic compound to be used is not particularly limited as long as it can provide a basic environment and contribute to the progress of the dehydration condensation reaction, and is, for example, 0.1 to 1000mmol, more preferably 1 to 50mmol, relative to 1mmol of the compound represented by formula (2).
According to the invention, the organic solvent is, for example, chloroform and/or dichloromethane. The amount of the organic solvent to be used may be, for example, 20 to 500mL (preferably 40 to 400mL) per 1mmol of the compound represented by the formula (2).
According to the present invention, preferably, the dehydration condensation reaction conditions include: the temperature is 20-100 deg.C (such as 50-100 deg.C), and the time is 10min-48h (such as 10-20 h). More preferably, the conditions of the dehydration condensation reaction include: the temperature is 60-80 ℃ and the time is 10-15 h.
In order to ensure the smooth proceeding of the reaction, the method further comprises maintaining the reaction system under an inert atmosphere before the reaction, for example, after all the raw materials are added, the non-reactive gas may be introduced into the reaction system for 20-40min to remove air. The inert gas may be, for example, argon, helium, nitrogen, or the like.
According to the present invention, in order to extract the compound represented by the formula (1F) from the reaction solution, the method further comprises a post-treatment step, for example, mixing the dehydration condensation reaction product with methanol (the amount of methanol may be, for example, 200-1000mL relative to the total volume of 100mL of the reaction solution), then carrying out solid-liquid separation, and carrying out chromatographic separation on the obtained solid phase by using a silica gel chromatographic column (200-300 mesh silica gel may be used, and the eluent may be a mixed solution of petroleum ether and dichloromethane in a volume ratio of 1: 0.2-3).
The invention also provides a poly-fused ring conjugated macromolecule, which is a compound shown in the following formula (1):
formula (1)
Figure BDA0001173383070000164
Wherein each group
Figure BDA0001173383070000165
Each independently represents 3 to 10
A thiophene conjugated fused ring structure; each group A' is independently selected from one of the groups represented by the following formulas:
Figure BDA0001173383070000166
wherein R is3-R6Each independently selected from H, alkyl, alkoxy, and alkylthio; wherein each R is1Each independently selected from the group consisting of
Figure BDA0001173383070000171
A group shown and formula
Figure BDA0001173383070000172
A group shown; each R is2Each independently selected from the group consisting of
Figure BDA0001173383070000173
A group shown; each Z is independently selected from C, N and Si; each X and each Y is independently selected from O, S and Se; m is an integer of 0 to 6; p is an integer of 0 to 6; n is an integer of 0 to 6; each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, C1-C30 alkylthio, and C6-C12 aryl.
According to the invention, the groups in the polya-fused ring conjugated macromolecule may be chosen from those described above, for which reason the invention is not described again for each group.
Wherein, preferably, each group
Figure BDA0001173383070000174
Each independently represents 3 to 5 thiophene conjugated fused ring structures; r3-R6Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, and C1-C30 alkylthio; each Z is independently selected from C, N and Si; each X and each Y is independently selected from O and S; m is an integer of 0 to 4; p is an integer of 0 to 4; n is an integer of 0 to 4; each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, C1-C20 alkylthio, and C6-C10 aryl.
More preferably, each group
Figure BDA0001173383070000175
Each independently represents 3 to 4 thiophene conjugated fused ring structures; r3-R6Each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, and C1-C20 alkylthio; each Z is independently selected from C and N; each R is7Each R9And each R11Each independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy, and C1-C6 alkylthio; each R is8And each R10And each independently selected from the group consisting of H, C4-C10 alkyl, C4-C10 alkoxy, and C4-C10 alkylthio.
Even more preferably, R3-R6Each independently selected from the group consisting of H, C1-C10 alkyl, C1-C10 alkoxy, and C1-C10 alkylthio; each Z is independently selected from C and N; m is 0, 1, 2 or 3; p is 0, 1, 2 or 3; n is 0, 1, 2 or 3; each R is7Each R9And each R11Each independently selected from H, methyl, ethyl, n-propyl, n-butyl, methoxy, ethoxy, n-propoxy, n-butoxy, methylthio, ethylthio, n-propylthio, and n-butylthio; each R is8And each R10And each is independently selected from the group consisting of H, n-butyl, n-pentyl, n-hexyl, n-octyl, 2-ethylhexyl, n-butoxy, n-pentoxy, n-hexoxy, n-octoxy, 2-ethylhexoxy, n-butylthio, n-pentoxy, n-hexoxy, n-octoxy, and 2-ethylhexoxy.
Preferably, the multiple fused ring conjugated macromolecule is one of the compounds shown in the following formula:
formula (1-9):
Figure BDA0001173383070000176
(corresponding to 3 thiophene conjugated condensed ring structures in all groups B);
formula (1-11):
Figure BDA0001173383070000177
(corresponding to 4 thiophene conjugated condensed ring structures in all groups B). Preferably, the group A 'is a group A' -1
Figure BDA0001173383070000181
According to the present invention, a specific example of the above-mentioned polyacondensed ring conjugated macromolecule may be one of compounds represented by the following formulae:
formula (1-9-1): in the formula (1-9), Z is C, A 'is a group A' -1, R2Is absent, R1Are both n-hexyl; formula (1-9-2): in the formula (1-9), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure BDA0001173383070000182
And R is10Is n-hexyl; formula (1-9-3): in the formula (1-9), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure BDA0001173383070000183
And R is8Is n-hexyl; formula (1-11-1): in the formula (1-11), Z is C, A 'is a group A' -1, R2Is absent, R1Are both n-hexyl; formula (1-11-2): in the formula (1-11), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure BDA0001173383070000184
And R is10Is n-hexyl; formula (1-11-3): in the formula (1-11), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure BDA0001173383070000185
And R is8Is n-hexyl.
The invention also provides a preparation method of the poly-fused ring conjugated macromolecule, which comprises the following steps:
subjecting a compound represented by the following formula (2) and a compound represented by the formula (a') to a dehydration condensation reaction in the presence of a basic compound and in an organic solvent to obtain a compound represented by the formula (1); wherein the content of the first and second substances,
formula (2)
Figure BDA0001173383070000186
Formula (a')
Figure BDA0001173383070000187
In the method, the group
Figure BDA0001173383070000188
R1-R6As described above, the present invention is not described in detail herein.
Wherein, the compound shown in the formula (2) is described above, and the invention is not repeated herein.
The compound represented by the formula (a ') may be appropriately selected according to the group a ', and for example, specific examples of the compound represented by the formula (a ') may include: formula (a' -1)
Figure BDA0001173383070000189
According to the present invention, the aldehyde group connected to both ends of the compound represented by formula (2) can be subjected to dehydration condensation with the compound represented by formula (a ') to form the compound represented by formula (1), wherein the amount of the compound represented by formula (2) and the compound represented by formula (a ') used is not particularly limited as long as the compound represented by formula (1) can be obtained, and preferably, the molar ratio of the compound represented by formula (2) to the compound represented by formula (a ') is 1: 2-100, more preferably 1: 4-10.
According to the present invention, the reaction is carried out in the presence of a basic compound, so that a basic environment can be provided to the reaction system, and the kind and amount of the basic compound can be selected as described hereinabove.
According to the present invention, the kind and amount of the organic solvent may be selected as described hereinabove.
According to the present invention, preferably, the dehydration condensation reaction conditions include: the temperature is 20-100 deg.C (such as 50-100 deg.C), and the time is 10min-48h (such as 10-20 h). More preferably, the conditions of the dehydration condensation reaction include: the temperature is 60-80 ℃ and the time is 10-15 h.
In order to ensure the smooth proceeding of the reaction, the method further comprises maintaining the reaction system under an inert atmosphere before the reaction, for example, after all the raw materials are added, the non-reactive gas may be introduced into the reaction system for 20-40min to remove air. The inert gas may be, for example, argon, helium, nitrogen, or the like.
According to the present invention, in order to extract the compound represented by the formula (1) from the reaction solution, the method further comprises a post-treatment step, for example, mixing the dehydration condensation reaction product with methanol (the amount of methanol may be, for example, 200-1000mL relative to the total volume of 100mL of the reaction solution), then carrying out solid-liquid separation, and carrying out chromatographic separation on the obtained solid phase by using a silica gel chromatographic column (200-300 mesh silica gel may be used, and the eluent may be a mixed solution of petroleum ether and dichloromethane in a volume ratio of 1: 0.2-3).
The invention also provides a photovoltaic material containing one or more of the poly-fused ring conjugated macromolecules.
According to the present invention, the photovoltaic material is not particularly limited as long as it contains the above-mentioned multiple-fused ring conjugated macromolecule of the present invention, and the photovoltaic material preferably refers to an electron donor material and/or an electron acceptor material in a light trapping active layer in a solar cell.
For example, the electron donor polymer material PBnDT-FTAZ may be mixed with the conjugated macromolecule provided by the present invention in a weight ratio of 0.5 to 4: 1 as a photovoltaic material, in particular as a photovoltaic material for a light-trapping active layer of a solar cell, wherein the conjugated macromolecules provided by the invention act as electron acceptor materials.
The structural units of the polymer material PBnDT-FTAZ are respectively as follows:
Figure BDA0001173383070000191
wherein-C6H13Represents n-hexyl, -C4H9Represents a n-butyl group. The preparation of the polymer material PBnDT-FTAZ can be carried out, for example, by methods in references (e.g., j.am. chem. soc.2011,133,4625), and the present invention is not described herein again.
The invention also provides a solar cell which comprises a light-trapping active layer, wherein the electron donor material and/or the electron acceptor material in the light-trapping active layer contain one or more of the poly-fused ring conjugated macromolecules.
According to the present invention, the structure of the solar cell is not particularly limited as long as the electron donor material and/or the electron acceptor material in the active layer for light trapping thereof contains the above-mentioned conjugated macromolecule, so that the photoelectric conversion efficiency of the solar cell can be effectively improved.
In particular, the conjugated macromolecules of the invention are suitable for use in organic solar cells, in particular as electron acceptor materials in combination with other electron donor materials to form a light-trapping active layer of a solar cell. As such an electron donor material there may be mentioned, for example, the polymeric material PBnDT-FTAZ, as defined above.
Wherein, the polymer material PBnDT-FTAZ can be mixed with the conjugated macromolecule provided by the invention in a weight ratio of 0.5-4: 1 are combined to form the active layer for light trapping.
The invention also provides a preparation method of the solar cell, wherein the method comprises the step of using an electron donor material and/or an electron acceptor material containing one or more of the multi-fused ring conjugated macromolecules to form a light-trapping active layer.
According to the present invention, the process for preparing the solar cell is not particularly limited, and may be performed by a method conventional in the art, for example, the process may include:
coating a ZnO layer as a cathode modification layer (with the thickness of 20-50nm for example) on conductive glass (such as indium tin oxide glass and ITO) as a cathode, drying, coating a mixture of a polymer material PBnDT-FTAZ and the conjugated macromolecules provided by the invention as an active layer on the ZnO layer, drying, and performing vacuum evaporation on molybdenum oxide (with the thickness of 5-10nm for example) and Ag (with the thickness of 50-100nm for example) as an anode.
The conjugated macromolecule provided by the invention has a stronger visible light absorption peak, for example, a strong absorption peak in the wavelength range of 600-850 nm; the conjugated macromolecule has good thermal stability, can resist the temperature of about 310 ℃ without decomposition; the cyclic voltammetry test result shows that the HOMO energy level and the LUMO energy level of the material can be matched with the energy levels of most common electron donor materials, and the material has better capability of accepting electrons or holes, and is very favorable for being used as a photovoltaic material of a solar cell, in particular to an electron acceptor and/or an electron donor material, especially as an electron acceptor material.
The solar cell provided by the invention has high short-circuit current, such as 15mA cm-2Above, preferably up to 20mA cm-2(ii) a A high open circuit voltage, for example, 0.8V or more, preferably 0.9V or more; higher filling factor, for example, up to 65% or more, preferably up to 70% or more; a high photoelectric conversion rate (PCE) may be, for example, 8.9% or more, preferably 12%.
The present invention will be described in detail below by way of examples.
In the following examples:1h NMR was measured using a nuclear magnetic resonance apparatus model AVANCE 400 from Bruker. MS (MALDI) was measured using a Bruker Daltonics Biflex III MALDI-TOF Analyzer model mass spectrometer. The UV-visible absorption spectrum was measured using a Jasco V-570spectrophotometer model UV-visible spectrophotometer. The cyclic voltammogram was measured using a cyclic voltammeter model CHI660C electrochemical work. The I-V curve is measured by B2912A Precision Source/measurement Unit (Agilent Technologies), from which parameters such as short-circuit current, open-circuit voltage, fill factor, and photoelectric conversion efficiency can be obtained. The polymer donor material PBnDT-FTAZ was prepared by the method in document j.am.chem.soc.2011,133, 4625.
Preparation example 1
This preparation example is illustrative of the method for producing the compound represented by the formula (2-7-2).
Figure BDA0001173383070000201
As shown in the above reaction scheme, a compound represented by the formula IT (102mg, 0.1 mmol; available from South technologies, Inc., Nakay, Suzhou), tetrahydrofuran (20mL) was addedArgon was introduced into the reaction vessel and stirred at-78 ℃ for 1 h. N-butyllithium (0.19mL, 0.3mmol,1.6M) was slowly added dropwise, stirred at-78 deg.C for 2h, N-dimethylformamide (36.6mg, 0.5mmol) was added, and the reaction product was slowly brought to room temperature (about 25 deg.C) and stirred overnight (about 12 h). Then, water (0.2mL) was added for quenching, extraction was performed with saturated brine and dichloromethane, drying was performed with magnesium sulfate, and spin-drying was performed to obtain a precipitate, which was chromatographed on a silica gel column (using 200-300 mesh silica gel, eluent petroleum ether/dichloromethane in a volume ratio of 2: 1) to obtain a bright yellow solid (91mg, yield 84.6%), which was the compound represented by the formula (2-7-2).1H NMR(400MHz,CDCl3):δ9.89(s,2H),7.94(s,2H),7.62(s,2H),7.16(d,J=8.4Hz,8H),7.11(d,J=8.4Hz,8H),2.58(t,J=7.6Hz,8H),1.66(m,8H),1.31(m,24H),0.89(m,12H).MS(MALDI):m/z 1077(M+1).
Preparation example 2
This preparation example is illustrative of the method for producing the compound represented by the formula (2-7-3).
Figure BDA0001173383070000211
As shown in the above reaction formula, a compound represented by the formula IT-Th (104mg, 0.1 mmol; available from Solomon organic photoelectric technology, Beijing, Ltd.) and tetrahydrofuran (20mL) were added to a reaction vessel, and stirred at-78 ℃ for 1 hour under argon gas. N-butyllithium (0.2mL, 0.32mmol,1.6M) was slowly added dropwise, stirred at-78 deg.C for 2h, N-dimethylformamide (32.9mg, 0.45mmol) was added, and the reaction product was slowly brought to room temperature (about 25 deg.C) and stirred overnight (about 12 h). Then, water (0.2mL) was added for quenching, extraction was performed with saturated brine and dichloromethane, drying was performed with magnesium sulfate, and spin-drying was performed to obtain a precipitate, which was chromatographed on a silica gel column (using 200-mesh 300-mesh silica gel, eluent petroleum ether/dichloromethane in a volume ratio of 1.5: 1) to obtain a bright yellow solid (65mg, yield 59.1%), which was the compound represented by the formula (2-7-3).1H NMR(400MHz,CDCl3):δ9.94(s,2H),7.97(s,2H),7.79(s,2H),6.81(d,J=3.2Hz,4H),6.57(d,J=3.6Hz,4H),2.71(t,J=7.6Hz,8H),1.61(m,8H),1.33(m,24H),0.87(m,12H).MS(MALDI):m/z 1099(M+).
Preparation example 3
This preparation example is illustrative of the method for producing the compound represented by the formula (2-9-2).
Figure BDA0001173383070000212
As shown in the above reaction scheme, a compound represented by formula IBT (226mg, 0.2 mmol; available from Soviet Nakay technologies, Ltd.) and tetrahydrofuran (35mL) were charged into a reaction vessel, and stirred at-78 ℃ for 1 hour under argon. N-butyllithium (0.4mL, 0.64mmol,1.6M) was slowly added dropwise, stirred at-78 deg.C for 1.5h, N-dimethylformamide (65.8mg, 0.9mmol) was added, and the reaction product was slowly brought to room temperature (about 25 deg.C) and stirred overnight (about 12 h). Then adding water (0.4mL) for quenching, extracting by using saturated brine and dichloromethane, drying by magnesium sulfate, spin-drying, and carrying out chromatographic separation on the obtained precipitate by using a silica gel chromatographic column (200-300-mesh silica gel is adopted, and the eluent is petroleum ether/dichloromethane with the volume ratio of 1: 1) to obtain an orange-red solid (159mg, the yield is 67 percent), namely the compound shown as the formula (2-9-2).1H NMR(400MHz,CDCl3):δ9.88(s,2H),7.88(s,2H),7.62(s,2H),7.18(d,J=8.1Hz,8H),7.10(d,J=8.1Hz,8H),2.54(t,J=7.8Hz,8H),1.55(m,8H),1.27(m,24H),0.83(t,J=6.6Hz,12H).MS(MALDI):m/z 1187(M+).
Preparation example 4
This preparation example is illustrative of the method for producing the compound represented by the formula (2-11-2).
Figure BDA0001173383070000221
As shown in the above reaction scheme, a compound represented by the formula ITT (186.4mg, 0.15 mmol; available from Scotch technologies, Suzhou), tetrahydrofuran (30mL) was charged into a reaction vessel, and stirred at-78 ℃ for 1h under argon. N-butyllithium (0.38mL, 0.6mmol,1.6M) was slowly added dropwise, stirred at-78 deg.C for 1.5h, N-dimethylformamide (51.2mg, 0.7mmol) was added, the reaction product was slowly brought to room temperature (about 25 deg.C), stirred overnight(about 12 h). Then, water (0.4mL) was added for quenching, extraction was performed with saturated brine and dichloromethane, drying was performed with magnesium sulfate, spin-drying was performed, and the obtained precipitate was chromatographed on a silica gel column (using 200-mesh 300-mesh silica gel, eluent petroleum ether/dichloromethane in a volume ratio of 1: 1) to obtain a red solid (106mg, yield 54.4%), which was the compound represented by the formula (2-11-2).1H NMR(400MHz,CDCl3):δ9.81(s,2H),7.86(s,2H),7.60(s,2H),7.19(d,J=8.1Hz,8H),7.04(d,J=8.1Hz,8H),2.46(t,J=7.8Hz,8H),1.52(m,8H),1.24(m,24H),0.82(t,J=6.6Hz,12H).MS(MALDI):m/z 1298(M+).
Preparation example 5
This preparation example is intended to illustrate the preparation of the compounds represented by the formulae (a-2) and (a-3).
Figure BDA0001173383070000222
As shown in the above reaction scheme, 5-fluoro-1, 3-indandione (820mg, 5 mmol; from Ark Co.), malononitrile (660mg, 10mmol), and ethanol (30mL) were charged into a reaction vessel, and stirred at 25 ℃ for 30 minutes under argon. Sodium acetate (492mg, 6mmol) was added slowly and stirred at 25 ℃ for 2h, water (40mL) was added and stirred for 1.5 h. Then, concentrated hydrochloric acid was added to adjust the pH to 2, and the mixture was filtered through a filter paper, washed with water (300mL), and the obtained precipitate was chromatographed on a silica gel column (using 200-mesh 300-mesh silica gel, and the eluent was methanol/chloroform at a volume ratio of 1: 5) to obtain an off-white solid (610mg, yield 57.5%) which was a mixture of the compound represented by the formula (a-2) (71 mol%) and the compound represented by the formula (a-3) (29 mol%). Of mixtures1H NMR(400MHz,CDCl3):δ8.68(dd,J=8.8Hz,0.28H),7.61(dd,J=8.2Hz,0.72H),8.01(m,0.76H),7.61(m,0.36H),7.55(m,1H),3.76(d,2H).MS(EI):m/z 212(M+).
Preparation example 6
This preparation example is illustrative of the method for producing the compound represented by the formula (a-1).
Figure BDA0001173383070000231
As shown in the above reaction scheme, 4-fluoro-1, 3-indandione (410mg, 2.5 mmol; available from Ark Co.), malononitrile (330mg, 5mmol), and ethanol (20mL) were charged into a reaction vessel, and stirred at 25 ℃ for 30 minutes under argon. Sodium acetate (246mg, 3mmol) was added slowly and stirred at 25 ℃ for 2h, water (30mL) was added and stirred for 1.5 h. Then, concentrated hydrochloric acid was added to adjust the pH to 2, the mixture was filtered through filter paper and washed with water (300mL), and the obtained precipitate was chromatographed on a silica gel column (200-mesh 300-mesh silica gel was used and the eluent was methanol/chloroform at a volume ratio of 1: 2) to obtain a brown solid (190mg, yield 35.8%), which was the compound represented by the formula (a-1).1H NMR(400MHz,CDCl3):δ8.48(d,J=8.1Hz,1H),7.89(m,1H),7.49(t,J=8.4Hz,1H),3.76(s,2H).MS(EI):m/z 212(M+).
Preparation example 7
This preparation example is illustrative of the method for producing the compound represented by the formula (a-5).
Figure BDA0001173383070000232
As shown in the above reaction scheme, 5, 6-difluoro-1, 3-indandione (201mg, 1.1 mmol; synthesized according to the method in Planells, M.; Robertson, N.Eur.J.Org.chem.2012,2012, 4947), malononitrile (145mg, 2.2mmol), ethanol (20mL) were added to the reaction vessel, and the mixture was stirred at 25 ℃ for 30 minutes under argon. Sodium acetate (107mg, 1.3mmol) was added slowly and stirred at 25 ℃ for 2h, water (30mL) was added and stirred for 1.5 h. Then, concentrated hydrochloric acid was added to adjust the pH to 2, the mixture was filtered through a filter paper and washed with water (400mL), and the obtained precipitate was chromatographed on a silica gel column (200-mesh 300-mesh silica gel was used and the eluent was methanol/chloroform at a volume ratio of 1: 1) to obtain a brown solid (115mg, yield 44.6%), which was the compound represented by the formula (a-5).1H NMR(400MHz,CDCl3):δ8.46(dd,J=6.4Hz,1H),7.76(t,J=7.6Hz,1H),3.76(s,2H).MS(EI):m/z 230(M+).
Example 1
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000241
As shown in the above reaction scheme, a compound represented by the formula (2-5-2) (96.3mg, 0.1 mmol; available from Soochet technologies, Inc., Nakai, Suzhou), a mixture (84.8mg, 0.4mmol) of the compound represented by the formula (a-2) and the compound represented by the formula (a-3) obtained in the above preparation example 5, pyridine (0.6mL, 0.72mmol) and chloroform (35mL) were charged into a reaction vessel, purged with argon for 20min, and then refluxed at 65 ℃ for 15 h. After cooling to room temperature (about 25 ℃ C.), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographed on a silica gel column (using 200-300 mesh silica gel with petroleum ether/dichloromethane as an eluent in a volume ratio of 1: 1) to give a deep blue solid (87mg, yield 64%) which is a mixture of the multiple-and fused-ring conjugated macromolecules represented by the formula (1F-5-F1) which is a compound represented by the formula (1F-5-5), the formula (1F-5-8) and the formula (1F-5-35). Of mixtures1HNMR(400MHz,CDCl3):δ8.89(d,2H),8.71(dd,J=4.8Hz,0.6H),8.38(dd,J=8.8Hz,1.4H),7.91(dd,J=5.2Hz,1.4H),7.73(t,J=4.4Hz,4H),7.54(dd,J=2.8Hz,0.6H),7.42(m,2H),7.13(d,J=8.4Hz,16H),2.58(t,J=7.6Hz,8H),1.61(m,8H),1.30(m,24H),0.88(m,12H).MS(MALDI):m/z 1351.8(M+1).
The UV-visible absorption spectrum of the mixture of the three poly-fused ring conjugated macromolecules represented by the formula (1F-5-F1) is shown in FIG. 1, wherein the mixture has a strong absorption peak in the wavelength range of 600-750nm and the maximum molar extinction coefficient of 2.42 × 105M–1·cm–1The film absorbs most strongly at 704 nm.
The cyclic voltammogram is shown in FIG. 2, the HOMO energy level is-5.84 eV, the LUMO energy level is-3.93 eV, and the band gap is 1.91eV, which shows that the mixture of the three poly-fused ring conjugated macromolecules shown in the formula (1F-5-F1) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 2
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000242
As shown in the above reaction scheme, a compound represented by the formula (2-5-1) (66mg, 0.1 mmol; available from Solidago organic photoelectric technology (Beijing) Co., Ltd.), a mixture (84.8mg, 0.4mmol) of the compounds represented by the formulae (a-2) and (a-3) obtained in the above preparation example 5, pyridine (0.65mL, 0.78mmol) and chloroform (30mL) were charged into a reaction vessel, purged with argon for 15min, followed by refluxing at 65 ℃ for 13 h. After cooling to room temperature (about 25 ℃ C.), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographed on a silica gel column (using 200-300 mesh silica gel with an eluent of petroleum ether/dichloromethane in a volume ratio of 1: 1.5) to give a brown solid (67mg, yield 64%) which was a mixture of the multiple-and-fused ring conjugated macromolecules represented by the formula (1F-5-F2) which was the compounds represented by the formula (1F-5-4), the formula (1F-5-7) and the formula (1F-5-34). Of mixtures1H NMR(400MHz,CDCl3):δ8.98(d,2H),8.74(dd,J=4.4Hz,0.6H),8.40(d,J=8.8Hz,1.4H),7.95(dd,J=6.4Hz,1.4H),7.73(d,2H),7.61(s,2H),7.58(m,0.6H),7.44(t,J=6.4Hz,2H),2.07(m,4H),1.95(m,4H),1.14(m,24H),0.78(m,20H).MS(MALDI):m/z 1047(M+1).
The UV-visible absorption spectrum of the mixture of the three poly-fused ring conjugated macromolecules represented by the formula (1F-5-F2) is shown in FIG. 3, wherein the mixture has a strong absorption peak in the wavelength range of 600-800nm and the maximum molar extinction coefficient of 2.12X 105M–1·cm–1The film absorbs most strongly at around 730 nm.
The cyclic voltammogram is shown in FIG. 4, the HOMO level is-5.72 eV, the LUMO level is-3.99 eV, and the band gap is 1.73eV, which shows that the mixture of the three poly-fused ring conjugated macromolecules shown in the formula (1F-5-F2) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 3
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000251
As shown in the above reaction scheme, a compound represented by the formula (2-5-1) (100mg, 0.15 mmol; available from Solomon organic photoelectric technology (Beijing) Co., Ltd.), a compound represented by the formula (a-5) (138mg, 0.6mmol), pyridine (0.7mL, 0.84mmol) and chloroform (35mL) were charged into a reaction vessel, and the reaction was refluxed at 65 ℃ for 14 hours under argon gas for 15 minutes. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographically separated by using a silica gel chromatography column (200-300 mesh silica gel was used, and the eluent was petroleum ether/dichloromethane at a volume ratio of 3: 1) to obtain a dark brown solid (93mg, yield 57%) which was the poly-fused ring conjugated macromolecule represented by the formula (1F-5-13).1H NMR(400MHz,CDCl3):δ8.98(s,2H),8.57(dd,J=6.4Hz,2H),7.72(m,4H),7.62(s,2H),2.08(m,4H),1.95(m,4H),1.14(m,24H),0.8(m,20H).MS(MALDI):m/z 1084(M+1).
The UV-visible absorption spectrum of the conjugated macromolecule with multiple condensed rings shown in the formula (1F-5-13) is shown in FIG. 5, wherein the UV-visible absorption spectrum has a strong absorption peak in the wavelength range of 600-750nm, and the maximum molar extinction coefficient is 2.4 × 105M–1·cm–1The film absorbs most strongly at around 724 nm.
The cyclic voltammogram is shown in FIG. 6, the HOMO energy level is-5.73 eV, the LUMO energy level is-4.06 eV, and the band gap is 1.67eV, which shows that the poly-fused ring conjugated macromolecule shown in the formula (1F-5-13) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 4
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000261
As shown in the above reaction scheme, a mixture of the compound represented by the formula (2-7-2) (110mg, 0.1mmol), the compound represented by the formula (a-2) and the compound represented by the formula (a-3) obtained in the above production example 5The mixture (84.8mg, 0.4mmol), pyridine (0.7mL, 0.84mmol) and chloroform (35mL) were added to the reaction vessel, purged with argon for 15min, and then refluxed at 65 ℃ for 16 h. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographed on a silica gel column (using 200-300 mesh silica gel with an eluent of petroleum ether/dichloromethane at a volume ratio of 1: 1) to give a bluish black solid (110mg, yield 75%) as a mixture of the multiple-and-fused ring-conjugated macromolecules represented by formula (1F-7-F1), which is a compound represented by formula (1F-7-5), formula (1F-7-8) and formula (1F-7-35). Of mixtures1H NMR(400MHz,CDCl3):δ8.60(s,2H),8.71(dd,J=4.0Hz,0.5H),8.36(dd,J=1.6Hz,1.5H),8.23(d,J=7.6Hz,2H),7.92(dd,J=5.2Hz,1.5H),7.64(s,2H),7.55(dd,J=2.8Hz,0.5H),7.41(m,2H),7.21(d,J=8.4Hz,8H),7.14(d,J=8.4Hz,8H),2.57(t,J=8Hz,8H),1.61(m,8H),1.29(m,24H),0.86(t,J=6.4Hz,12H).MS(MALDI):m/z 1463.7(M+1).
The UV-visible absorption spectrum of the mixture of the three poly-fused ring conjugated macromolecules represented by the formula (1F-7-F1) is shown in FIG. 7, wherein the mixture has a strong absorption peak in the wavelength range of 600-800nm and the maximum molar extinction coefficient of 2.2X 105M–1·cm–1The film has the strongest absorption at the position of about 734 nm; the maximum absorption peak of the film is 48nm red-shifted from the solution.
The cyclic voltammogram is shown in FIG. 8, the HOMO level is-5.63 eV, the LUMO level is-3.98 eV, and the band gap is 1.65eV, which shows that the mixture of the three poly-fused ring conjugated macromolecules shown in the formula (1F-7-F1) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 5
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000262
As shown in the above reaction scheme, a compound represented by the formula (2-7-3) (110mg, 0.1mmol), the formula (a-2) obtained in the above production example 5 anda mixture (84.8mg, 0.4mmol) of the compound represented by the formula (a-3), pyridine (0.7mL, 0.84mmol) and chloroform (30mL) were added to a reaction vessel, and argon was introduced for 25min, followed by reflux at 65 ℃ for 15 h. After cooling to room temperature (about 25 ℃ C.), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographed on a silica gel column (using 200-300 mesh silica gel with petroleum ether/dichloromethane as an eluent in a volume ratio of 1: 1) to give a turquoise solid (75mg, yield 50.4%) which was a mixture of the multiple-and-fused ring conjugated macromolecules represented by the formula (1F-7-F3) which was the compounds represented by the formula (1F-7-6), the formula (1F-7-9) and the formula (1F-7-36). Of mixtures1H NMR(400MHz,CDCl3):δ8.90(s,2H),8.72(dd,J=4.4Hz,0.4H),8.39(d,1.6H),8.27(d,2H),7.94(dd,J=5.2Hz,1.6H),7.82(s,2H),7.58(dd,J=2.4Hz,0.4H),7.42(m,2H),6.88(m,4H),6.61(m,4H),2.72(t,J=2.4Hz,8H),1.64(m,8H),1.27(m,24H),0.83(m,12H).MS(MALDI):m/z 1488(M+1).
The UV-visible absorption spectrum of the mixture of the three poly-fused ring conjugated macromolecules represented by the formula (1F-7-F3) is shown in FIG. 9, wherein the mixture has a strong absorption peak in the wavelength range of 600-800nm and the maximum molar extinction coefficient of 1.79X 105M–1·cm–1The film absorbs most strongly at around 728 nm.
The cyclic voltammogram is shown in FIG. 10, the HOMO level is-5.74 eV, the LUMO level is-4.01 eV, and the band gap is 1.73eV, which shows that the mixture of the three poly-fused ring conjugated macromolecules shown in the formula (1F-7-F3) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 6
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000271
As shown in the above reaction scheme, a compound represented by the formula (2-7-3) (165mg, 0.15mmol), a compound represented by the formula (a-5) (127mg, 0.6mmol), pyridine (0.9mL, 1.08mmol) and chloroform (40mL) were added to a reaction vesselArgon was introduced into the vessel for 30min, followed by reflux at 65 ℃ for 16 h. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographically separated by using a silica gel chromatography column (200-300 mesh silica gel was used, and the eluent was petroleum ether/dichloromethane at a volume ratio of 3: 1) to obtain a dark green solid (100mg, yield 44%), which was the poly-fused ring conjugated macromolecule represented by the formula (1F-7-15).1H NMR(400MHz,CDCl3):δ8.89(s,2H),8.55(t,J=8.8Hz,2H),8.27(s,2H),7.83(d,2H),7.70(t,J=7.6Hz,2H),6.88(m,4H),6.61(m,4H),2.72(t,J=8.0Hz,8H),1.62(m,8H),1.31(m,24H),0.82(m,12H).MS(MALDI):m/z 1523(M+1).
The UV-visible absorption spectrum of the conjugated macromolecule with multiple condensed rings shown in the formula (1F-7-15) is shown in FIG. 11, wherein the UV-visible absorption spectrum has a strong absorption peak in the wavelength range of 600-800nm, and the maximum molar extinction coefficient is 2.23 × 105M–1·cm–1The film has the strongest absorption at about 736 nm.
The cyclic voltammogram is shown in FIG. 12, the HOMO energy level is-5.75 eV, the LUMO energy level is-4.07 eV, and the band gap is 1.68eV, which shows that the poly-fused ring conjugated macromolecule shown in the formula (1F-7-15) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 7
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000281
As shown in the above reaction scheme, a compound represented by the formula (2-9-2) (154mg, 0.13mmol), a mixture (106mg, 0.5mmol) of the compounds represented by the formulae (a-2) and (a-3) obtained in the above production example 5, pyridine (0.9mL, 1.08mmol) and chloroform (30mL) were charged into a reaction vessel, passed through argon for 30min, and then refluxed at 65 ℃ for 14 h. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the resulting precipitate was chromatographed on a silica gel column (200-300 mesh silica gel was used, eluent was petroleum ether/dichloromethane in a volume ratio of 1: 1)And separating to obtain a turquoise solid (100mg, the yield is 48.8 percent), namely the poly-fused ring conjugated macromolecule shown as the formula (1F-9-F1), which is a mixture of the compounds shown as the formula (1F-9-5), the formula (1F-9-8) and the formula (1F-9-35). Of mixtures1H NMR(400MHz,CDCl3):δ8.91(d,2H),8.67(dd,J=4.4Hz,0.5H),8.35(d,1.5H),7.96(d,J=10.8Hz,2H),7.90(dd,J=5.2Hz,1.5H),7.64(s,2H),7.53(m,0.5H),7.37(m,2H),7.21(d,J=8.4Hz,8H),7.14(d,J=8Hz,8H),2.59(t,J=8Hz,8H),1.61(m,8H),1.30(m,24H),0.87(m,12H).MS(MALDI):m/z1475.9(M+1).
The UV-visible absorption spectrum of the mixture of the three poly-fused ring conjugated macromolecules represented by the formula (1F-9-F1) is shown in FIG. 13, wherein the mixture has a strong absorption peak in the wavelength range of 600-800nm and the maximum molar extinction coefficient of 2.11X 105M–1·cm–1The film absorbs most strongly at around 728 nm.
The cyclic voltammogram is shown in FIG. 14, the HOMO level is-5.44 eV, the LUMO level is-3.98 eV, and the band gap is 1.46eV, which shows that the mixture of the three poly-fused ring conjugated macromolecules shown in the formula (1F-9-F1) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 8
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000282
As shown in the above reaction scheme, a compound represented by the formula (2-9-2) (120mg, 0.1mmol), a compound represented by the formula (a-1) (84mg, 0.4mmol), pyridine (0.8mL, 0.96mmol) and chloroform (35mL) were charged into a reaction vessel, purged with argon for 25min, and then refluxed at 65 ℃ for 14 h. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographically separated by means of a silica gel column (using 200-300 mesh silica gel and an eluent of petroleum ether/dichloromethane in a volume ratio of 1: 2) to obtain a turquoise solid (75mg, yield 47.5%) which was the multiple fused ring-sharing solid represented by the formula (1F-9-2)The yoke is a macromolecule.1H NMR(400MHz,CDCl3):δ8.94(s,2H),8.48(d,J=8Hz,2H),7.96(s,2H),7.69(m,2H),7.64(s,2H),7.33(t,J=8.4Hz,2H),7.2(d,J=8.4Hz,8H),7.14(d,J=8.4Hz,8H),2.58(t,J=7.6Hz,8H),1.61(m,8H),1.29(m,24H),0.86(t,J=6.4Hz,12H).MS(MALDI):m/z 1576.1(M+1).
The UV-visible absorption spectrum of the conjugated macromolecule with multiple condensed rings shown in the formula (1F-9-2) is shown in FIG. 15, wherein the UV-visible absorption spectrum has a strong absorption peak in the wavelength range of 600-800nm, and the maximum molar extinction coefficient is 2.22 × 105M–1·cm–1The film absorbs most strongly at around 720 nm.
The cyclic voltammogram is shown in FIG. 16, the HOMO energy level is-5.46 eV, the LUMO energy level is-3.98 eV, and the band gap is 1.48eV, which shows that the poly-fused ring conjugated macromolecule shown in the formula (1F-9-2) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 9
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000291
As shown in the above reaction scheme, a compound represented by the formula (2-9-2) (154mg, 0.13mmol), a compound represented by the formula (a-5) (116mg, 0.55mmol), pyridine (0.9mL, 1.08mmol) and chloroform (35mL) were charged into a reaction vessel, purged with argon for 25min, and then refluxed at 65 ℃ for 15 h. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographically separated by using a silica gel chromatography column (200-300 mesh silica gel was used, and the eluent was petroleum ether/dichloromethane at a volume ratio of 2: 1) to obtain a black-green solid (95mg, yield 45.5%) which was the poly-fused ring conjugated macromolecule represented by the formula (1F-9-14).1H NMR(400MHz,CDCl3):δ8.91(s,2H),8.53(dd,J=3.6Hz,2H),7.98(s,2H),7.67(m,4H),7.20(d,8H),7.14(d,8H),2.58(t,J=8.0Hz,8H),1.62(m,8H),1.27(m,24H),0.87(m,12H).MS(MALDI):m/z 1612(M+1).
The formula (1F-9-14)The UV-visible absorption spectrum of the polycyclic conjugated macromolecule is shown in FIG. 17, wherein the UV-visible absorption spectrum has a strong absorption peak in the wavelength range of 600-800nm and the maximum molar extinction coefficient is 2.51 × 105M–1·cm–1The film absorbs most strongly at around 744 nm.
The cyclic voltammogram is shown in FIG. 18, the HOMO energy level is-5.49 eV, the LUMO energy level is-4.02 eV, and the band gap is 1.47eV, which shows that the poly-fused ring conjugated macromolecule shown in the formula (1F-9-14) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 10
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000301
As shown in the above reaction scheme, a compound represented by the formula (2-9-2) (120mg, 0.1mmol), a compound represented by the formula (a' -1) (78mg, 0.4 mmol; available from TCI Co., Ltd.), pyridine (0.8mL, 0.96mmol) and chloroform (30mL) were charged into a reaction vessel, purged with argon for 25min, and then refluxed at 65 ℃ for 15 h. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographically separated by using a silica gel column (200-300 mesh silica gel was used, and the eluent was petroleum ether/dichloromethane at a volume ratio of 1: 2) to obtain a turquoise solid (115mg, yield 74.6%), which was the poly-fused ring conjugated macromolecule represented by the formula (1-9-2).1H NMR(400MHz,CDCl3):δ8.92(d,J=3.6Hz,2H),8.67(m,2H),7.91(dd,J=6.8Hz,4H),7.69(m,4H),7.64(s,2H),7.21(d,J=8Hz,8H),7.15(d,J=8Hz,8H),2.58(t,J=8Hz,8H),1.62(m,8H),1.30(m,24H),0.86(t,J=6.4Hz,12H).MS(MALDI):m/z1539.4(M+1).
The UV-visible absorption spectrum of the conjugated macromolecule with multiple fused rings shown in the formula (1-9-2) is shown in FIG. 19, wherein the UV-visible absorption spectrum has a strong absorption peak in the wavelength range of 600-800nm, and the maximum molar extinction coefficient is 2.09X 105M–1·cm–1The film absorbs most strongly at about 706 nm; film(s)The maximum absorption peak of (a) is shifted 14nm more than the red in solution.
The cyclic voltammogram is shown in FIG. 20, the HOMO energy level is-5.41 eV, the LUMO energy level is-3.90 eV, and the band gap is 1.51eV, which shows that the poly-fused ring conjugated macromolecule shown in the formula (1-9-2) has better electron accepting capability and can be matched with the energy level of most common electron donor materials.
Example 11
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000302
As shown in the above reaction scheme, a compound represented by the formula (2-11-2) (130mg, 0.1mmol), a mixture (84mg, 0.4mmol) of the compounds represented by the formulae (a-2) and (a-3) obtained in preparation example 5 above, pyridine (0.7mL, 0.84mmol) and chloroform (40mL) were charged into a reaction vessel, purged with argon for 25min, and then refluxed at 65 ℃ for 13 h. After cooling to room temperature (about 25 ℃ C.), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographically separated by means of a silica gel column (using 200-300 mesh silica gel and an eluent of petroleum ether/chloroform in a volume ratio of 1: 2) to obtain a dark green solid (83mg, yield 49%) which was a mixture of the multiple-and-fused ring conjugated macromolecules represented by the formula (1F-11-F1) which was the compounds represented by the formula (1F-11-5), the formula (1F-11-8) and the formula (1F-11-35). Of mixtures1H NMR(400MHz,CDCl3):δ8.93(d,J=6.4Hz,2H),8.72(dd,J=4.4Hz,0.5H),8.41(d,J=8.8Hz,1.5H),8.03(d,J=10.8Hz,2H),7.94(dd,J=5.2Hz,1.5H),7.71(s,2H),7.59(m,0.5H),7.42(m,2H),7.24(d,J=8.4Hz,8H),7.17(d,J=8Hz,8H),2.63(t,J=8Hz,8H),1.67(m,8H),1.33(m,24H),0.89(m,12H).MS(MALDI):m/z 1689(M+1).
Example 12
This example serves to illustrate the conjugated macromolecules of the invention and their preparation.
Figure BDA0001173383070000311
As shown in the above reaction scheme, a compound represented by the formula (2-11-2) (130mg, 0.1mmol), a compound represented by the formula (a' -1) (78mg, 0.4 mmol; available from TCI Co., Ltd.), pyridine (0.8mL, 0.96mmol) and chloroform (30mL) were charged into a reaction vessel, purged with argon for 25min, and then refluxed at 65 ℃ for 14 h. After cooling to room temperature (about 25 ℃), the reaction product was poured into 200mL of methanol and filtered, and the obtained precipitate was chromatographically separated by using a silica gel column (200-300 mesh silica gel was used, and the eluent was petroleum ether/dichloromethane at a volume ratio of 1: 2) to obtain a turquoise solid (78mg, yield 47%), which was the poly-fused ring conjugated macromolecule represented by the formula (1-11-2).1H NMR(400MHz,CDCl3):δ8.94(s,2H),8.81(m,2H),8.33(dd,J=6.8Hz,4H),7.96(m,4H),7.76(s,2H),7.23(d,J=8Hz,8H),7.18(d,J=8Hz,8H),2.60(t,J=8Hz,8H),1.63(m,8H),1.32(m,24H),0.88(t,J=6.4Hz,12H).MS(MALDI):m/z1653(M+1).
Example 13
This example serves to illustrate the solar cell of the present invention.
Indium Tin Oxide (ITO) glass (purchased from Shenzhen glass float glass Co., Ltd.) as a cathode is cleaned by a detergent, then sequentially cleaned by deionized water, acetone and isopropanol in an ultrasonic mode, a ZnO cathode modification layer with the thickness of 30nm is coated in a spin mode after drying, and the ZnO cathode modification layer is dried for 30 minutes at the temperature of 200 ℃ for later use.
1.5mg of the mixture of the three poly-fused ring conjugated macromolecules represented by the formula (1F-5-F1) and 1mg of the polymer donor material PBnDT-FTAZ were mixed in 0.1mL of chloroform to obtain a mixed solution, which was spin-coated on the ZnO layer, and dried to obtain a light trapping active layer (having an effective area of 4 mm)2). Vacuum (absolute pressure 2X 10) on the active layer- 5Pa) vapor deposition thickness of about 5nm of MoO3(available from carbofuran technologies, inc.) and about 80nm of metallic Ag as the anode of the solar cell.
A solar light source was simulated with an AM1.5 filter (model XES-70S1, SAN-EI ELECTRIC Co., Ltd.) at 100mW/cm2The devices were tested for photovoltaic performance at light intensity calibrated by standard single crystal silicon solar cells (available from VLSI Standards Inc). The obtained I-V kojiThe lines were measured using B2912A Precision Source/measurement Unit (Agilent Technologies) and controlled by computer via Labview software.
The resulting I-V curve is shown in FIG. 21. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 21oc0.72V, short-circuit current JscIs 12.7mA cm-2The fill factor FF is 62% and the photoelectric conversion efficiency PCE is 5.7%.
Example 14
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F2) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 22. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 22oc0.74V, short-circuit current JscIs 15.5mA cm-2The fill factor FF is 66.7%, and the photoelectric conversion efficiency PCE is 7.63%.
Example 15
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the polyacene ring conjugated macromolecule represented by the formula (1F-5-13) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 23. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 23oc0.65V, short-circuit current JscIs 14.7mA · cm-2The fill factor FF is 62.3%, and the photoelectric conversion efficiency PCE is 5.93%.
Example 16
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-7-F1) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 24. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 24oc0.79V, short-circuit current JscIs 15.3mA cm-2The fill factor FF was 61.5% and the photoelectric conversion efficiency PCE was 7.47%.
Example 17
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-7-F3) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 25. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 25oc0.84V, short-circuit current JscIs 19.7mA · cm-2The fill factor FF is 74% and the photoelectric conversion efficiency PCE is 12.1%.
Example 18
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the polyacene ring conjugated macromolecule represented by the formula (1F-7-15) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 26. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 26oc0.75V, short-circuit current JscIs 17.2mA · cm-2The fill factor FF is 70% and the photoelectric conversion efficiency PCE is 9.2%.
Example 19
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-9-F1) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 27. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 27oc0.90V, short-circuit current JscIs 17.7mA · cm-2The fill factor FF is 67.8%, and the photoelectric conversion efficiency PCE is 10.8%.
Example 20
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the polyacene ring conjugated macromolecule represented by the formula (1F-9-2) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 28. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 28oc0.93V, short-circuit current JscIs 16.7mA cm-2The fill factor FF is 64.8%, and the photoelectric conversion efficiency PCE is 10.1%.
Example 21
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the polyacene ring conjugated macromolecule represented by the formula (1F-9-14) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 29. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 29oc0.85V, short-circuit current JscIs 19.68mA · cm-2The fill factor FF is 68.5% and the photoelectric conversion efficiency PCE is 11.5%.
Example 22
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the polyacene ring conjugated macromolecule represented by the formula (1-9-2) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 30. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 30oc0.97V, short-circuit current JscIs 13.4mA cm-2The fill factor FF is 59.5%, and the photoelectric conversion efficiency PCE is 7.69%.
Example 23
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-11-F1) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 31. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 31oc0.91V, short-circuit current JscIs 17.3mA · cm-2The fill factor FF is 71% and the photoelectric conversion efficiency PCE is 11.2%.
Example 24
This example serves to illustrate the solar cell of the present invention.
A solar cell was finally prepared and tested according to the procedure described in example 13, except that 1.5mg of the polyacene ring conjugated macromolecule represented by the formula (1-11-2) was used in place of the mixture of three polyacene ring conjugated macromolecules represented by the formula (1F-5-F1).
The resulting I-V curve is shown in FIG. 32. The open circuit voltage V of the solar cell can be obtained by the I-V curve shown in FIG. 32oc0.92V, short-circuit current JscIs 14.5mA cm-2The fill factor FF is 60% and the photoelectric conversion efficiency PCE is 8%.
The preferred embodiments of the present invention have been described in detail, however, the present invention is not limited to the specific details of the above embodiments, and various simple modifications may be made to the technical solution of the present invention within the technical idea of the present invention, and these simple modifications are within the protective scope of the present invention.
It should be noted that the various technical features described in the above embodiments can be combined in any suitable manner without contradiction, and the invention is not described in any way for the possible combinations in order to avoid unnecessary repetition.
In addition, any combination of the various embodiments of the present invention is also possible, and the same should be considered as the disclosure of the present invention as long as it does not depart from the spirit of the present invention.

Claims (27)

1. A multiple-fused ring conjugated macromolecule, wherein the conjugated macromolecule is a compound represented by the following formula (1F):
formula (1F)
Figure FDA0002333815440000011
Wherein each group
Figure FDA0002333815440000012
Each independently represents 2 to 10 thiophene conjugated fused ring structures;
each group A is independently selected from one of the groups shown in the following formulas:
Figure FDA0002333815440000013
wherein R is3-R6At least one of which is F, the others are each independently selected from H, alkyl, alkoxy and alkylthio;
wherein each R is1Each independently selected from the group consisting of
Figure FDA0002333815440000014
A group shown and formula
Figure FDA0002333815440000015
A group shown;
each R is2Each independently selected from the group consisting of
Figure FDA0002333815440000016
A group shown;
each Z is independently selected from C, N and Si;
each X and each Y is independently selected from O, S and Se;
m is an integer of 0 to 6;
p is an integer of 0 to 6;
n is an integer of 0 to 6;
each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, C1-C30 alkylthio, and C6-C12 aryl.
2. The polya-fused ring conjugated macromolecule of claim 1, wherein each group is
Figure FDA0002333815440000017
Each independently represents 2 to 5 thiophene conjugated fused ring structures; r3-R6At least one of which is F, the others are each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, and C1-C30 alkylthio; each Z is independently selected from C, N and Si; each X and each Y is independently selected from O and S; m is an integer of 0 to 4; p is an integer of 0 to 4; n is an integer of 0 to 4; each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, C1-C20 alkylthio, and C6-C10 aryl.
3. The polya-fused ring conjugated macromolecule of claim 2, wherein each group is
Figure FDA0002333815440000021
Each independently represents 2 to 4 thiophene conjugated fused ring structures; r3-R6At least one of which is F, the others are each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, and C1-C20 alkylthio; each Z is independently selected from C and N; each R is7Each R9And each R11Each independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy, and C1-C6 alkylthio; each R is8And each R10And each independently selected from the group consisting of H, C4-C10 alkyl, C4-C10 alkoxy, and C4-C10 alkylthio.
4. The polya-fused ring conjugated macromolecule of claim 3, wherein R3-R6At least one of which is F, the others are each independently selected from the group consisting of H, C1-C10 alkyl, C1-C10 alkoxy, and C1-C10 alkylthio; each Z is independently selected from C and N; m is 0, 1, 2 or 3; p is 0, 1, 2 or 3; n is 0, 1, 2 or 3; each R is7Each R9And each R11Each independently selected from H, methyl, ethyl, n-propyl, n-butyl, methoxy, ethoxy, n-propoxy, n-butoxy, methylthio, ethylthio, n-propylthio, and n-butylthio; each R is8And each R10And each is independently selected from the group consisting of H, n-butyl, n-pentyl, n-hexyl, n-octyl, 2-ethylhexyl, n-butoxy, n-pentoxy, n-hexoxy, n-octoxy, 2-ethylhexoxy, n-butylthio, n-pentoxy, n-hexoxy, n-octoxy, and 2-ethylhexoxy.
5. The poly-fused ring conjugated macromolecule of claim 1, wherein the conjugated macromolecule is one of the compounds represented in the following formula:
formula (1F-7):
Figure FDA0002333815440000022
formula (1F-9):
Figure FDA0002333815440000023
formula (1F-11):
Figure FDA0002333815440000024
6. the poly-fused ring conjugated macromolecule of claim 5, wherein the definition: the radical A-1 is
Figure FDA0002333815440000031
The group A-2 is
Figure FDA0002333815440000032
The radical A-3 is
Figure FDA0002333815440000033
The group A-4 is
Figure FDA0002333815440000034
The radical A-5 is
Figure FDA0002333815440000035
The radical A-6 is
Figure FDA0002333815440000036
The radical A-7 is
Figure FDA0002333815440000037
The radical A-8 is
Figure FDA0002333815440000038
The radical A-9 is
Figure FDA0002333815440000039
The radical A-10 is
Figure FDA00023338154400000310
The radical A-11 is
Figure FDA00023338154400000311
The conjugated macromolecule is one of the compounds shown in the following formula:
formula (1F-7-1): in the formula (1F-7), Z is C, A is A-1, R2Is absent, R1Are both n-hexyl;
formula (1F-7-2): in the formula (1F-7), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure FDA00023338154400000312
And R is10Is n-hexyl;
formula (1F-7-3): in the formula (1F-7), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure FDA00023338154400000313
And R is8Is n-hexyl;
formula (1F-7-4): in the formula (1F-7), Z is C, A is A-2, R2Is absent, R1Are both n-hexyl;
formula (1F-7-5): in the formula (1F-7), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure FDA00023338154400000314
And R is10Is n-hexyl;
formula (1F-7-6): in the formula (1F-7), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure FDA00023338154400000315
And R is8Is n-hexyl;
formula (1F-7-7): in the formula (1F-7), Z is C, A is A-3, R2Is absent, R1Are both n-hexyl;
formula (1F-7-8): in the formula (1F-7), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure FDA00023338154400000316
And R is10Is n-hexyl;
formula (1F-7-9): in the formula (1F-7), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure FDA00023338154400000317
And R is8Is n-hexyl;
formula (1F-7-10): in the formula (1F-7), Z is C, A is A-4, R2Is absent, R1Are both n-hexyl;
formula (1F-7-11): in the formula (1F-7), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure FDA0002333815440000041
And R is10Is n-hexyl;
formula (1F-7-12): in the formula (1F-7), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure FDA0002333815440000042
And R is8Is n-hexyl;
formula (1F-7-13): in the formula (1F-7), Z is C, A is A-5, R2Is absent, R1Are both n-hexyl;
formula (1F-7-14): in the formula (1F-7), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure FDA0002333815440000043
And R is10Is n-hexyl;
formula (1F-7-15): in the formula (1F-7), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure FDA0002333815440000044
And R is8Is n-hexylA group;
formula (1F-7-16): in the formula (1F-7), Z is C, A is A-6, R2Is absent, R1Are both n-hexyl;
formula (1F-7-17): in the formula (1F-7), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure FDA0002333815440000045
And R is10Is n-hexyl;
formula (1F-7-18): in the formula (1F-7), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure FDA0002333815440000046
And R is8Is n-hexyl;
formula (1F-7-19): in the formula (1F-7), Z is C, A is a group A-7, R2Is absent, R1Are both n-hexyl;
formula (1F-7-20): in the formula (1F-7), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure FDA0002333815440000047
And R is10Is n-hexyl;
formula (1F-7-21): in the formula (1F-7), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure FDA0002333815440000048
And R is8Is n-hexyl;
formula (1F-7-22): in the formula (1F-7), Z is C, A is A-8, R2Is absent, R1Are both n-hexyl;
formula (1F-7-23): in the formula (1F-7), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure FDA0002333815440000049
And R is10Is n-hexyl;
formula (1F-7-24): in the formula (1F-7), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure FDA00023338154400000410
And R is8Is n-hexyl;
formula (1F-7-25): in the formula (1F-7), Z is C, A is A-9, R2Is absent, R1Are both n-hexyl;
formula (1F-7-26): in the formula (1F-7), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure FDA00023338154400000411
And R is10Is n-hexyl;
formula (1F-7-27): in the formula (1F-7), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure FDA00023338154400000412
And R is8Is n-hexyl;
formula (1F-7-28): in the formula (1F-7), Z is C, A is A-10, R2Is absent, R1Are both n-hexyl;
formula (1F-7-29): in the formula (1F-7), Z is C, A is A-10, R2Is absent, R1Are all made of
Figure FDA0002333815440000051
And R is10Is n-hexyl;
formula (1F-7-30): in the formula (1F-7), Z is C, A is A-10, R2Is absent, R1Are all made of
Figure FDA0002333815440000052
And R is8Is n-hexyl;
formula (1F-7-31): in the formula (1F-7), Z is C, A is a group A-11, R2Is absent, R1Are both n-hexyl;
formula (1)F-7-32): in the formula (1F-7), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure FDA0002333815440000053
And R is10Is n-hexyl;
formula (1F-7-33): in the formula (1F-7), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure FDA0002333815440000054
And R is8Is n-hexyl;
formula (1F-7-34): in the formula (1F-7), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are both n-hexyl;
formula (1F-7-35): in the formula (1F-7), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000055
And R is10Is n-hexyl;
formula (1F-7-36): in the formula (1F-7), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000056
And R is8Is n-hexyl;
formula (1F-9-1): in the formula (1F-9), Z is C, A is A-1, R2Is absent, R1Are both n-hexyl;
formula (1F-9-2): in the formula (1F-9), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure FDA0002333815440000057
And R is10Is n-hexyl;
formula (1F-9-3): in the formula (1F-9), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure FDA0002333815440000058
And R is8Is n-hexyl;
formula (1F-9-4): in the formula (1F-9), Z is C, A is A-2, R2Is absent, R1Are both n-hexyl;
formula (1F-9-5): in the formula (1F-9), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure FDA0002333815440000059
And R is10Is n-hexyl;
formula (1F-9-6): in the formula (1F-9), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure FDA00023338154400000510
And R is8Is n-hexyl;
formula (1F-9-7): in the formula (1F-9), Z is C, A is A-3, R2Is absent, R1Are both n-hexyl;
formula (1F-9-8): in the formula (1F-9), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000061
And R is10Is n-hexyl;
formula (1F-9-9): in the formula (1F-9), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000062
And R is8Is n-hexyl;
formula (1F-9-10): in the formula (1F-9), Z is C, A is A-4, R2Is absent, R1Are both n-hexyl;
formula (1F-9-11): in the formula (1F-9), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure FDA0002333815440000063
And R is10Is n-hexyl;
formula (1F-9-12): in the formula (1F-9), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure FDA0002333815440000064
And R is8Is n-hexyl;
formula (1F-9-13): in the formula (1F-9), Z is C, A is A-5, R2Is absent, R1Are both n-hexyl;
formula (1F-9-14): in the formula (1F-9), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure FDA0002333815440000065
And R is10Is n-hexyl;
formula (1F-9-15): in the formula (1F-9), Z is C, A is A-5, R2Is absent, R1Are all made of
Figure FDA0002333815440000066
And R is8Is n-hexyl;
formula (1F-9-16): in the formula (1F-9), Z is C, A is A-6, R2Is absent, R1Are both n-hexyl;
formula (1F-9-17): in the formula (1F-9), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure FDA0002333815440000067
And R is10Is n-hexyl;
formula (1F-9-18): in the formula (1F-9), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure FDA0002333815440000068
And R is8Is n-hexyl;
formula (1F-9-19): in the formula (1F-9), Z is C, A is a group A-7, R2Is absent, R1Are both n-hexyl;
formula (1F-9-20): in the formula (1F-9), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure FDA0002333815440000069
And R is10Is n-hexyl;
formula (1F-9-21): in the formula (1F-9), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure FDA00023338154400000610
And R is8Is n-hexyl;
formula (1F-9-22): in the formula (1F-9), Z is C, A is A-8, R2Is absent, R1Are both n-hexyl;
formula (1F-9-23): in the formula (1F-9), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure FDA00023338154400000611
And R is10Is n-hexyl;
formula (1F-9-24): in the formula (1F-9), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure FDA00023338154400000612
And R is8Is n-hexyl;
formula (1F-9-25): in the formula (1F-9), Z is C, A is A-9, R2Is absent, R1Are both n-hexyl;
formula (1F-9-26): in the formula (1F-9), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure FDA0002333815440000071
And R is10Is n-hexyl;
formula (1F-9-27)): in the formula (1F-9), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure FDA0002333815440000072
And R is8Is n-hexyl;
formula (1F-9-28): in the formula (1F-9), Z is C, A is a group A-10, R2Is absent, R1Are both n-hexyl;
formula (1F-9-29): in the formula (1F-9), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure FDA0002333815440000073
And R is10Is n-hexyl;
formula (1F-9-30): in the formula (1F-9), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure FDA0002333815440000074
And R is8Is n-hexyl;
formula (1F-9-31): in the formula (1F-9), Z is C, A is a group A-11, R2Is absent, R1Are both n-hexyl;
formula (1F-9-32): in the formula (1F-9), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure FDA0002333815440000075
And R is10Is n-hexyl;
formula (1F-9-33): in the formula (1F-9), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure FDA0002333815440000076
And R is8Is n-hexyl;
formula (1F-9-34): in the formula (1F-9), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are both n-hexyl;
formula (1F-9-35): in the formula (1F-9), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000077
And R is10Is n-hexyl;
formula (1F-9-36): in the formula (1F-9), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000078
And R is8Is n-hexyl;
formula (1F-11-1): in the formula (1F-11), Z is C, A is A-1, R2Is absent, R1Are both n-hexyl;
formula (1F-11-2): in the formula (1F-11), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure FDA0002333815440000079
And R is10Is n-hexyl;
formula (1F-11-3): in the formula (1F-11), Z is C, A is A-1, R2Is absent, R1Are all made of
Figure FDA00023338154400000710
And R is8Is n-hexyl;
formula (1F-11-4): in the formula (1F-11), Z is C, A is A-2, R2Is absent, R1Are both n-hexyl;
formula (1F-11-5): in the formula (1F-11), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure FDA0002333815440000081
And R is10Is n-hexyl;
formula (1F-11-6): in the formula (1F-11), Z is C, A is A-2, R2Is absent, R1Are all made of
Figure FDA0002333815440000082
And R is8Is n-hexyl;
formula (1F-11-7): in the formula (1F-11), Z is C, A is A-3, R2Is absent, R1Are both n-hexyl;
formula (1F-11-8): in the formula (1F-11), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000083
And R is10Is n-hexyl;
formula (1F-11-9): in the formula (1F-11), Z is C, A is A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000084
And R is8Is n-hexyl;
formula (1F-11-10): in the formula (1F-11), Z is C, A is A-4, R2Is absent, R1Are both n-hexyl;
formula (1F-11-11): in the formula (1F-11), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure FDA0002333815440000085
And R is10Is n-hexyl;
formula (1F-11-12): in the formula (1F-11), Z is C, A is A-4, R2Is absent, R1Are all made of
Figure FDA0002333815440000086
And R is8Is n-hexyl;
formula (1F-11-13): in the formula (1F-11), Z is C, A is a group A-5, R2Is absent, R1Are both n-hexyl;
formula (1F-11-14): in the formula (1F-11), Z is C, A is a group A-5, R2Is absent, R1Are all made of
Figure FDA0002333815440000087
And R is10Is n-hexyl;
formula (1F-11-15): in the formula (1F-11), Z is C, A is a group A-5, R2Is absent, R1Are all made of
Figure FDA0002333815440000088
And R is8Is n-hexyl;
formula (1F-11-16): in the formula (1F-11), Z is C, A is A-6, R2Is absent, R1Are both n-hexyl;
formula (1F-11-17): in the formula (1F-11), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure FDA0002333815440000089
And R is10Is n-hexyl;
formula (1F-11-18): in the formula (1F-11), Z is C, A is A-6, R2Is absent, R1Are all made of
Figure FDA00023338154400000810
And R is8Is n-hexyl;
formula (1F-11-19): in the formula (1F-11), Z is C, A is a group A-7, R2Is absent, R1Are both n-hexyl;
formula (1F-11-20): in the formula (1F-11), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure FDA0002333815440000091
And R is10Is n-hexyl;
formula (1F-11-21): in the formula (1F-11), Z is C, A is a group A-7, R2Is absent, R1Are all made of
Figure FDA0002333815440000092
And R is8Is n-hexyl;
formula (1F-11-22): in the formula (1F-11), Z is C, A is A-8, R2Is absent, R1Are both n-hexyl;
formula (1F-11-23): in the formula (1F-11), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure FDA0002333815440000093
And R is10Is n-hexyl;
formula (1F-11-24): in the formula (1F-11), Z is C, A is A-8, R2Is absent, R1Are all made of
Figure FDA0002333815440000094
And R is8Is n-hexyl;
formula (1F-11-25): in the formula (1F-11), Z is C, A is A-9, R2Is absent, R1Are both n-hexyl;
formula (1F-11-26): in the formula (1F-11), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure FDA0002333815440000095
And R is10Is n-hexyl;
formula (1F-11-27): in the formula (1F-11), Z is C, A is A-9, R2Is absent, R1Are all made of
Figure FDA0002333815440000096
And R is8Is n-hexyl;
formula (1F-11-28): in the formula (1F-11), Z is C, A is a group A-10, R2Is absent, R1Are both n-hexyl;
formula (1F-11-29): in the formula (1F-11), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure FDA0002333815440000097
And R is10Is n-hexyl;
formula (1F-11-30): in the formula (1F-11), Z is C, A is a group A-10, R2Is absent, R1Are all made of
Figure FDA0002333815440000098
And R is8Is n-hexyl;
formula (1F-11-31): in the formula (1F-11), Z is C, A is a group A-11, R2Is absent, R1Are both n-hexyl;
formula (1F-11-32): in the formula (1F-11), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure FDA0002333815440000099
And R is10Is n-hexyl;
formula (1F-11-33): in the formula (1F-11), Z is C, A is a group A-11, R2Is absent, R1Are all made of
Figure FDA00023338154400000910
And R is8Is n-hexyl;
formula (1F-11-34): in the formula (1F-11), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are both n-hexyl;
formula (1F-11-35): in the formula (1F-11), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000101
And R is10Is n-hexyl;
formula (1F-11-36): in the formula (1F-11), Z is C, one A is a group A-2, the other A is a group A-3, R2Is absent, R1Are all made of
Figure FDA0002333815440000102
And R is8Is n-hexyl.
7. A method of preparing a polya-fused ring conjugated macromolecule of any of claims 1-6, comprising:
subjecting a compound represented by the following formula (2) and a compound represented by the formula (a) to a dehydration condensation reaction in the presence of a basic compound and in an organic solvent to obtain a compound represented by the formula (1F); wherein the content of the first and second substances,
formula (2)
Figure FDA0002333815440000103
Formula (a)
Figure FDA0002333815440000104
8. The method of claim 7, wherein the molar ratio of the compound of formula (2) to the compound of formula (a) is 1: 2-100.
9. The method of claim 7 or 8, wherein the conditions of the dehydration condensation reaction comprise: the temperature is 20-100 deg.C, and the time is 10min-48 h.
10. The method of claim 7, wherein the basic compound is one or more of piperidine, pyridine, and triethylamine.
11. The method according to claim 10, wherein the basic compound is used in an amount of 0.1 to 1000mmol relative to 1mmol of the compound represented by formula (2).
12. The method of claim 10, wherein the organic solvent is chloroform and/or dichloromethane.
13. A multiple-fused ring conjugated macromolecule, wherein the conjugated macromolecule is a compound represented by the following formula (1):
formula (1)
Figure FDA0002333815440000111
Wherein each group
Figure FDA0002333815440000112
Each independently represents 3 to 10 thiophene conjugated fused ring structures;
each group A' is independently selected from one of the groups represented by the following formulas:
Figure FDA0002333815440000113
wherein R is3-R6Each independently selected from H, alkyl, alkoxy, and alkylthio;
wherein each R is1Each independently selected from the group consisting of
Figure FDA0002333815440000114
A group shown and formula
Figure FDA0002333815440000115
A group shown;
each R is2Each independently selected from the group consisting of
Figure FDA0002333815440000116
A group shown;
each Z is independently selected from C, N and Si;
each X and each Y is independently selected from O, S and Se;
m is an integer of 0 to 6;
p is an integer of 0 to 6;
n is an integer of 0 to 6;
each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, C1-C30 alkylthio, and C6-C12 aryl.
14. The method of claim 13A polycyclic and fused ring conjugated macromolecule in which each group
Figure FDA0002333815440000117
Each independently represents 3 to 5 thiophene conjugated fused ring structures; r3-R6Each independently selected from the group consisting of H, C1-C30 alkyl, C1-C30 alkoxy, and C1-C30 alkylthio; each Z is independently selected from C, N and Si; each X and each Y is independently selected from O and S; m is an integer of 0 to 4; p is an integer of 0 to 4; n is an integer of 0 to 4; each R is7Each R8Each R9Each R10And each R11Each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, C1-C20 alkylthio, and C6-C10 aryl.
15. The polya-fused ring conjugated macromolecule of claim 14, wherein each group is
Figure FDA0002333815440000121
Each independently represents 3 to 4 thiophene conjugated fused ring structures; r3-R6Each independently selected from the group consisting of H, C1-C20 alkyl, C1-C20 alkoxy, and C1-C20 alkylthio; each Z is independently selected from C and N; each R is7Each R9And each R11Each independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy, and C1-C6 alkylthio; each R is8And each R10And each independently selected from the group consisting of H, C4-C10 alkyl, C4-C10 alkoxy, and C4-C10 alkylthio.
16. The polya-fused ring conjugated macromolecule of claim 15, wherein R3-R6Each independently selected from the group consisting of H, C1-C10 alkyl, C1-C10 alkoxy, and C1-C10 alkylthio; each Z is independently selected from C and N; m is 0, 1, 2 or 3; p is 0, 1, 2 or 3; n is 0, 1, 2 or 3; each R is7Each R9And each R11Each independently selected from H, methyl, ethyl, n-propyl, n-butyl, methoxy, ethoxy, n-propoxy, n-propylButoxy, methylthio, ethylthio, n-propylthio and n-butylthio; each R is8And each R10And each is independently selected from the group consisting of H, n-butyl, n-pentyl, n-hexyl, n-octyl, 2-ethylhexyl, n-butoxy, n-pentoxy, n-hexoxy, n-octoxy, 2-ethylhexoxy, n-butylthio, n-pentoxy, n-hexoxy, n-octoxy, and 2-ethylhexoxy.
17. The polya-fused ring conjugated macromolecule of claim 13, wherein the conjugated macromolecule is one of the compounds represented in the following formula:
formula (1-9):
Figure FDA0002333815440000122
formula (1-11):
Figure FDA0002333815440000123
18. the polya-fused ring conjugated macromolecule of claim 17, wherein,
defining: the radical A' -1 is
Figure FDA0002333815440000131
The conjugated macromolecule is one of the compounds shown in the following formula:
formula (1-9-1): in the formula (1-9), Z is C, A 'is a group A' -1, R2Is absent, R1Are both n-hexyl;
formula (1-9-2): in the formula (1-9), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure FDA0002333815440000132
And R is10Is n-hexyl;
formula (1-9-3): in the formula (1-9), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure FDA0002333815440000133
And R is8Is n-hexyl;
formula (1-11-1): in the formula (1-11), Z is C, A 'is a group A' -1, R2Is absent, R1Are both n-hexyl;
formula (1-11-2): in the formula (1-11), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure FDA0002333815440000134
And R is10Is n-hexyl;
formula (1-11-3): in the formula (1-11), Z is C, A 'is a group A' -1, R2Is absent, R1Are all made of
Figure FDA0002333815440000135
And R is8Is n-hexyl.
19. A method of preparing a polya-fused ring conjugated macromolecule of any of claims 13-18, comprising:
subjecting a compound represented by the following formula (2) and a compound represented by the formula (a') to a dehydration condensation reaction in the presence of a basic compound and in an organic solvent to obtain a compound represented by the formula (1); wherein the content of the first and second substances,
formula (2)
Figure FDA0002333815440000136
Formula (a')
Figure FDA0002333815440000137
20. The method of claim 19, wherein the molar ratio of the compound of formula (2) to the compound of formula (a') is 1: 2-100.
21. The method of claim 19 or 20, wherein the conditions of the dehydration condensation reaction comprise: the temperature is 20-100 deg.C, and the time is 10min-48 h.
22. The method of claim 19, wherein the basic compound is one or more of piperidine, pyridine, and triethylamine.
23. The method according to claim 22, wherein the basic compound is used in an amount of 0.1 to 1000mmol relative to 1mmol of the compound represented by formula (2).
24. The method of claim 22, wherein the organic solvent is chloroform and/or dichloromethane.
25. A photovoltaic material comprising one or more of the polya-fused ring conjugated macromolecules of any one of claims 1-6 and 13-18.
26. A solar cell comprising a light-trapping active layer, wherein an electron donor material and/or an electron acceptor material in the light-trapping active layer comprises one or more of the multiple-fused-ring conjugated macromolecules of any one of claims 1-6 and 13-18.
27. A method of producing a solar cell, wherein the method comprises using an electron donor material and/or an electron acceptor material comprising one or more of the multiple fused ring conjugated macromolecules of any one of claims 1-6 and 13-18 to form a light trapping active layer.
CN201611115692.XA 2016-12-07 2016-12-07 Poly-fused ring conjugated macromolecule and preparation method and application thereof Active CN108164547B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201611115692.XA CN108164547B (en) 2016-12-07 2016-12-07 Poly-fused ring conjugated macromolecule and preparation method and application thereof
PCT/CN2017/110174 WO2018103496A1 (en) 2016-12-07 2017-11-09 Polycyclic conjugated macromolecule and preparation method and application of same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611115692.XA CN108164547B (en) 2016-12-07 2016-12-07 Poly-fused ring conjugated macromolecule and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN108164547A CN108164547A (en) 2018-06-15
CN108164547B true CN108164547B (en) 2020-04-03

Family

ID=62490700

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611115692.XA Active CN108164547B (en) 2016-12-07 2016-12-07 Poly-fused ring conjugated macromolecule and preparation method and application thereof

Country Status (2)

Country Link
CN (1) CN108164547B (en)
WO (1) WO2018103496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108864142A (en) * 2018-07-27 2018-11-23 武汉理工大学 A kind of novel method for synthesizing of ITIC derivative
WO2020062254A1 (en) * 2018-09-30 2020-04-02 Southern University Of Science And Technology Chlorine atoms induced molecular interlocked network in a non-fullerene acceptor
WO2020085579A1 (en) * 2018-10-22 2020-04-30 경상대학교산학협력단 Novel spiro compound and organic electronic device using same
CN113242874B (en) * 2018-12-20 2023-12-12 三菱化学株式会社 Organic photodiode and infrared CMOS sensor
US11535631B2 (en) 2019-05-01 2022-12-27 The Hong Kong University Of Science And Technology Thiophene end groups of non-fullerene acceptors for electronic and photonic applications
CN110423245B (en) * 2019-08-27 2021-04-06 苏州潜寻新能源科技有限公司 A-D-A conjugated molecule, preparation method, application in organic solar cell and organic solar cell
CN112778327B (en) * 2019-11-11 2022-04-01 北京大学深圳研究生院 Organic non-fullerene electron acceptor material and preparation method and application thereof
CN111635319B (en) * 2020-06-30 2023-01-24 长江师范学院 Preparation method of compound with nitro-based electron-withdrawing group
CN113087720B (en) * 2021-03-03 2022-09-27 北京大学深圳研究生院 N-type organic semiconductor material based on benzothieno [3,2-b ] benzothiophene and preparation method and application thereof
CN113637023B (en) * 2021-08-16 2024-02-02 邵阳学院 Asymmetric indole derivative nuclear small molecule receptor material and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102482291A (en) * 2009-08-05 2012-05-30 剑桥显示技术有限公司 Organic semiconductors
CN105315298A (en) * 2014-08-04 2016-02-10 中国科学院化学研究所 A-D-A conjugated molecules based on hepta-condensed ring units and preparation method for A-D-A conjugated molecules and application of A-D-A conjugated molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734528B1 (en) * 2011-07-19 2017-03-29 Merck Patent GmbH Organic semiconductors
WO2013120575A1 (en) * 2012-02-16 2013-08-22 Merck Patent Gmbh Organic semiconducting polymers
CN104557968B (en) * 2013-10-29 2017-04-05 中国科学院化学研究所 A D A conjugated molecules based on dithieno indacene and its preparation method and application
KR101677841B1 (en) * 2014-04-21 2016-11-18 주식회사 엘지화학 Heterocyclic compound and organic solar cell comprising the same
WO2016171465A2 (en) * 2015-04-20 2016-10-27 주식회사 엘지화학 Heterocyclic compound and organic solar cell comprising same
CN106025073B (en) * 2016-06-14 2019-04-05 苏州大学 It is a kind of using ternary component as the organic solar batteries of active layer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102482291A (en) * 2009-08-05 2012-05-30 剑桥显示技术有限公司 Organic semiconductors
CN105315298A (en) * 2014-08-04 2016-02-10 中国科学院化学研究所 A-D-A conjugated molecules based on hepta-condensed ring units and preparation method for A-D-A conjugated molecules and application of A-D-A conjugated molecules

Also Published As

Publication number Publication date
WO2018103496A1 (en) 2018-06-14
CN108164547A (en) 2018-06-15

Similar Documents

Publication Publication Date Title
CN108164547B (en) Poly-fused ring conjugated macromolecule and preparation method and application thereof
CN108794504B (en) Multi-fused ring conjugated macromolecule and preparation method and application thereof
WO2021037278A1 (en) A-d-a conjugated molecule, preparation method therefor, use thereof in organic solar cell, and organic solar cell
WO2017107573A1 (en) Heptacyclic unit-based conjugated macromolecule, method of preparing same, and application thereof in solar cell
CN108912140A (en) A kind of asymmetry A-D-A type conjugation small molecule and its intermediate and application
CN104725613B (en) n-type water and alcohol soluble conjugated polymer material containing naphtho-diamide ring, and preparation method and application of material
CN108623614B (en) Conjugated molecule based on multi-combined five-membered ring and preparation method and application thereof
CN110128633B (en) Preparation method and application of low-HOMO energy level polymer donor material
CN105017264A (en) Organic small molecular photoelectric functional material, and preparation method thereof
CN105153189A (en) Narrow-band-gap oligomer containing quinone type Methyl-Dioxocyano-Pyridine unit, and preparation method and application thereof
CN110143976B (en) Synthesis method and application of branched porphyrin-perylene diimide-based small molecule receptor
JP2011165963A (en) Organic dye and organic thin-film solar cell
CN109956955B (en) Star-shaped D-A structure conjugated molecule based on benzo-tri (cyclopenta-bi-pentabasic aromatic heterocycle), and preparation method and application thereof
CN108084409B (en) Wide-band-gap organic semiconductor material and preparation method and application thereof
CN114716460A (en) Conjugated organic small molecule and preparation method and application thereof
CN109517142B (en) Star-shaped D-A structure conjugated molecule based on tri-indeno five-membered aromatic heterocycle, and preparation method and application thereof
CN109390469B (en) Application of multi-fused ring conjugated macromolecules in perovskite solar cell
CN116375732A (en) Non-fullerene acceptor material and preparation method and application thereof
CN108148182B (en) Conjugated compound based on cyclic imide fused benzothiadiazole, and preparation method and application thereof
CN110964040A (en) Benzoxadiazole-based acceptor material and preparation method and application thereof
Wu et al. Incorporation of diketopyrrolopyrrole dye to improve photovoltaic performance of P3HT: PC71BM based bulk heterojunction polymer solar cells
CN114106017B (en) Small molecular donor material containing benzothiophene, preparation method thereof and solar cell
Nolasco et al. Organoboron donor-π-acceptor chromophores for small-molecule organic solar cells
CN110982047B (en) Indacarbazine difuranyl organic solar cell donor material, and preparation method and application thereof
CN110386943B (en) Two-dimensional condensed ring conjugated macromolecule and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant